Compounds > choline
Page last updated: 2024-10-17

choline and Local Neoplasm Recurrence

choline has been researched along with Local Neoplasm Recurrence in 236 studies

Research Excerpts

ExcerptRelevanceReference
"This meta-analysis indicated 11C-choline has high diagnostic accuracy for the identification of tumor relapse from radiation induced necrosis in gliomas."8.98Accuracy of 11C-choline positron emission tomography in differentiating glioma recurrence from radiation necrosis: A systematic review and meta-analysis. ( Chen, G; Gao, L; Li, T; Xu, W; Zheng, J, 2018)
"In hepatocellular carcinoma (HCC) setting, 18 F-FDG and 18 F-choline PET/CT radiotracers are classically considered surrogates of the degree of differentiation, a strong predictor of disease recurrence after curative treatment."8.31Is 18 F-FDG/ 18 F-Choline Dual-Tracer PET Behavior a Surrogate of Tumor Differentiation in Hepatocellular Carcinoma : A Tertiary Center Dedicated Study. ( Besson, FL; Durand, E; Golse, N; Pascale, A; Sebagh, M; Sivapathasundaram, A, 2023)
"The aim of this study was to assess the prognostic performance of postoperative 18F-fluorocholine PET/CT in patients with high-grade glioma (HGG)."8.12Prognostic Potential of Postoperative 18F-Fluorocholine PET/CT in Patients With High-Grade Glioma. Clinical Validation of FuMeGA Postoperative PET Criteria. ( Amo-Salas, M; García Vicente, AM; López Menéndez, C; Pena Pardo, FJ; Pérez-Beteta, J; Soriano Castrejón, ÁM; Villena Martín, M, 2022)
"Patients with a previous gross total resection of glioma and the first suspicious or doubtful for recurrence MRI were prospectively included and subjected to 18 F-fluorocholine PET/CT."8.12Early Recurrence Detection of Glioma Using 18 F-Fluorocholine PET/CT : GliReDe Pilot Study. ( Amo-Salas, M; García Vicente, AM; Lozano Setien, E; Sandoval Valencia, H; Soriano Castrejón, ÁM, 2022)
" The purpose was to determine what proportion of a well-defined cohort of hormone-naïve patients who were candidates for early salvage radiotherapy had (18)F-choline PET/CT findings suggesting metastases."7.81(18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy. ( Ahlgren, G; Almquist, H; Bratt, O; Kjölhede, H; Liedberg, F; Lyttkens, K; Ohlsson, T, 2015)
"The aim of the present study is to evaluate the role of (11)C-choline positron emission tomography/computed tomography (PET/CT) in detecting tumor recurrence and predicting survival in post-treatment patients with high-grade gliomas."7.80(11)C-choline PET/CT tumor recurrence detection and survival prediction in post-treatment patients with high-grade gliomas. ( Hu, X; Li, W; Ma, L; Sun, J; Wang, S; Wang, X, 2014)
"The aim of this study is to assess the different metabolic activities characteristic of glioma recurrence and radiation necrosis (RN) and to explore the diagnostic accuracy for differentiation of the two conditions using (11)C-methionine (MET), (11)C-choline (CHO), and (18)F-fluorodeoxyglucose (FDG)-positron emission tomography (PET)."7.80Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis. ( Asano, Y; Iwama, T; Miwa, K; Nomura, Y; Shinoda, J; Takenaka, S; Yano, H; Yonezawa, S, 2014)
"Diagnosis of recurrent hepatocellular carcinoma (HCC) is sometimes challenging, especially when extrahepatic disease is present."5.43Recurrent Extrahepatic Hepatocellular Carcinoma Detected by 18F-Choline PET/CT. ( Geier, A; Götze, O; Lapa, C; Schmid, JS; Weiss, J, 2016)
"Lymph node metastasis was present in 32% of resected lymph nodes (681 of 2,122), resulting in 238 positive subregions and 111 positive regions."5.40Detection of lymph node metastasis in patients with nodal prostate cancer relapse using (18)F/(11)C-choline positron emission tomography/computerized tomography. ( Drendel, V; Grosu, AL; Henne, K; Hölz, S; Jandausch, A; Jilg, CA; Krauss, T; Reske, SN; Rischke, HC; Schultze-Seemann, W; Vach, W; Weber, WA; Wieser, G, 2014)
"Thirteen patients with recurrent glioblastoma were enrolled in RTOG 0625/ACRIN 6677, a prospective multicenter trial in which bevacizumab was used in combination with either temozolomide or irinotecan."5.17Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677. ( Barboriak, DP; Bokstein, F; Boxerman, JL; Gilbert, MR; McKinstry, RC; Ratai, EM; Safriel, Y; Snyder, BS; Sorensen, AG; Zhang, Z, 2013)
"This meta-analysis indicated 11C-choline has high diagnostic accuracy for the identification of tumor relapse from radiation induced necrosis in gliomas."4.98Accuracy of 11C-choline positron emission tomography in differentiating glioma recurrence from radiation necrosis: A systematic review and meta-analysis. ( Chen, G; Gao, L; Li, T; Xu, W; Zheng, J, 2018)
"In hepatocellular carcinoma (HCC) setting, 18 F-FDG and 18 F-choline PET/CT radiotracers are classically considered surrogates of the degree of differentiation, a strong predictor of disease recurrence after curative treatment."4.31Is 18 F-FDG/ 18 F-Choline Dual-Tracer PET Behavior a Surrogate of Tumor Differentiation in Hepatocellular Carcinoma : A Tertiary Center Dedicated Study. ( Besson, FL; Durand, E; Golse, N; Pascale, A; Sebagh, M; Sivapathasundaram, A, 2023)
"Findings will provide timely information on the safety, efficacy, and optimal dosing of t-PA to treat moderate/severe COVID-19-induced ARDS, which can be rapidly adapted to a phase III trial (NCT04357730; FDA IND 149634)."4.21 ( Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y, 2022)
"Patients with a previous gross total resection of glioma and the first suspicious or doubtful for recurrence MRI were prospectively included and subjected to 18 F-fluorocholine PET/CT."4.12Early Recurrence Detection of Glioma Using 18 F-Fluorocholine PET/CT : GliReDe Pilot Study. ( Amo-Salas, M; García Vicente, AM; Lozano Setien, E; Sandoval Valencia, H; Soriano Castrejón, ÁM, 2022)
"The aim of this study was to assess the prognostic performance of postoperative 18F-fluorocholine PET/CT in patients with high-grade glioma (HGG)."4.12Prognostic Potential of Postoperative 18F-Fluorocholine PET/CT in Patients With High-Grade Glioma. Clinical Validation of FuMeGA Postoperative PET Criteria. ( Amo-Salas, M; García Vicente, AM; López Menéndez, C; Pena Pardo, FJ; Pérez-Beteta, J; Soriano Castrejón, ÁM; Villena Martín, M, 2022)
"Age and choline/creatine ratio are strong independent prognostic factors in high grade gliomas."3.81Prognostic Value of MRS Metabolites in Postoperative Irradiated High Grade Gliomas. ( Kelekis, N; Kokakis, I; Kouloulias, V; Kouvaris, JR; Kyrgias, G; Mosa, E; Papathanasiou, M; Pissakas, G; Pistevou-Gombaki, K; Tolia, M; Tsoukalas, N; Verganelakis, D, 2015)
" The purpose was to determine what proportion of a well-defined cohort of hormone-naïve patients who were candidates for early salvage radiotherapy had (18)F-choline PET/CT findings suggesting metastases."3.81(18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy. ( Ahlgren, G; Almquist, H; Bratt, O; Kjölhede, H; Liedberg, F; Lyttkens, K; Ohlsson, T, 2015)
"Eighteen patients with newly diagnosed, histologically confirmed glioblastoma had 3D-MR proton spectroscopic imaging (MRSI) along with T2 and T1 gadolinium-enhanced MR images at simulation and at boost treatment planning after 17 to 20 fractions of radiation therapy."3.803-Dimensional magnetic resonance spectroscopic imaging at 3 Tesla for early response assessment of glioblastoma patients during external beam radiation therapy. ( Anderson, CM; Bayouth, JE; Buatti, JM; Capizzano, AA; Clerkin, PP; Magnotta, V; McGuire, SM; Morris, A; Muruganandham, M; Smith, BJ; Smith, MC, 2014)
"The aim of this study is to assess the different metabolic activities characteristic of glioma recurrence and radiation necrosis (RN) and to explore the diagnostic accuracy for differentiation of the two conditions using (11)C-methionine (MET), (11)C-choline (CHO), and (18)F-fluorodeoxyglucose (FDG)-positron emission tomography (PET)."3.80Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis. ( Asano, Y; Iwama, T; Miwa, K; Nomura, Y; Shinoda, J; Takenaka, S; Yano, H; Yonezawa, S, 2014)
"The aim of the present study is to evaluate the role of (11)C-choline positron emission tomography/computed tomography (PET/CT) in detecting tumor recurrence and predicting survival in post-treatment patients with high-grade gliomas."3.80(11)C-choline PET/CT tumor recurrence detection and survival prediction in post-treatment patients with high-grade gliomas. ( Hu, X; Li, W; Ma, L; Sun, J; Wang, S; Wang, X, 2014)
"The aim of this study was to assess the accuracy and clinical impact of [(11)C]choline PET/CT for localizing occult relapse of prostate adenocarcinoma after radical prostatectomy."3.74[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy. ( Blumstein, NM; Glatting, G; Reske, SN, 2008)
" Primary central nervous system lymphoma (PCNSL) is a highly aggressive tumor responsive to high-dose methotrexate based regimens."3.73Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma. ( Abrey, LE; DeAngelis, LM; Koutcher, JA; Lis, E; Panageas, KS; Raizer, JJ; Xu, S; Zakian, KL, 2005)
" We compared the LR sensitivity, specificity, and receiver operator characteristic (ROC) curve area (Az) with the sensitivity and specificity of blinded and unblinded qualitative MRS interpretations and a choline (Cho)/N-acetylaspartate (NAA) amplitude ratio criterion."3.70Discrimination between neoplastic and nonneoplastic brain lesions by use of proton MR spectroscopy: the limits of accuracy with a logistic regression model. ( Bowen, W; Butzen, J; Chetty, V; Donahue, K; Haughton, V; Kim, T; Krouwer, H; Li, SJ; Mark, L; Meyer, G; Mueller, W; Neppl, R; Prost, R; Rand, S, 2000)
"Seven patients responded to tamoxifen therapy (three with glioblastomas multiforme; four with anaplastic astrocytomas), and nine did not (six with glioblastomas multiforme; three with anaplastic astrocytomas)."3.70Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy. ( Arnold, DL; Caramanos, Z; Langleben, A; LeBlanc, R; Preul, MC; Shenouda, G; Villemure, JG, 2000)
"18F-Choline PET/CT (FCH) in prostate cancer (PCa) patients (pts) with biochemical recurrence (BCR)."3.30Comparison of 18F-PSMA-1007 and 18F-Choline PET/CT in prostate cancer patients with biochemical recurrence: a phase 3, prospective, multicenter, randomized study. ( Apostolopoulos, D; Chatzipavlidou, V; Datseris, I; Exarhos, D; Fragkiadaki, V; Klampatsas, A; Kypraios, C; Liatsikos, E; Panagiotidis, E; Papathanasiou, N; Paschali, A; Zarokosta, F, 2023)
"Postradiation treatment necrosis is one of the most serious late sequelae and appears within 6 months."3.01Brain magnetic resonance spectroscopy to differentiate recurrent neoplasm from radiation necrosis: A systematic review and meta-analysis. ( Aseel, A; McCarthy, P; Mohammed, A, 2023)
"Choline-PET/CT has a high global sensitivity while WB-DW-MRI has a high specificity, and so they are complementary techniques."2.84Whole-body diffusion-weighted magnetic resonance imaging (WB-DW-MRI) vs choline-positron emission tomography-computed tomography (choline-PET/CT) for selecting treatments in recurrent prostate cancer. ( Broseta-Torres, R; Conde-Moreno, AJ; Cozar-Santiago, MP; Ferrer-Albiach, C; Ferrer-Rebolleda, J; García-Piñón, F; Herrando-Parreño, G; Muelas-Soria, R, 2017)
"Twelve prostate cancer patients (nine staging, three re-staging) were included."2.80BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study). ( Beheshti, M; Dinkelborg, L; Haim, S; Kunit, T; Langsteger, W; Loidl, W; Schiller, C; Stephens, A; Zakavi, R, 2015)
"Twenty-six men (15 newly diagnosed with prostate cancer, 2 with recurrent prostate cancer, 6 with no evidence of prostate cancer recurrence after treatment, and 3 with no history of prostate cancer) underwent dual-phase PET consisting of initial whole-body PET starting 7 min after injection of 3."2.72Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET. ( Coel, MN; Kwee, SA; Sesterhenn, I; Wei, H; Yun, D, 2006)
"For the diagnosis of recurrent ovarian cancer (n = 3), (11)C-choline PET and (18)F-FDG PET were true-positive in 1 patient, whereas neither tracer could detect cystic recurrent tumor and microscopic peritoneal disease in the other 2 patients."2.71Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET. ( Futatsubashi, M; Kanno, T; Maeda, M; Nakamura, F; Okada, H; Ouchi, Y; Takekuma, M; Torizuka, T; Yoshikawa, E, 2003)
"11C-choline PET is a feasible technique for evaluation of treatment for localized prostate cancer."2.7111C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer. ( de Jong, IJ; Elsinga, PH; Mensink, HJ; Pruim, J; Vaalburg, W, 2003)
"The management of prostate cancer has dramatically changed over the last decades, mainly due to improvement of diagnostic modalities and development of new therapeutic strategies."2.66Prostate imaging: Contribution of PET PSMA and MRI. ( Abecassis, JP; Ghazzar, N; Giraud, P; Peyromaure, M, 2020)
"Imaging plays an increasing role in prostate cancer diagnosis and staging."2.66Positron emission tomography (PET) radiotracers for prostate cancer imaging. ( Choyke, PL; Lim, I; Lindenberg, L; Mena, E; Turkbey, B; Walker, SM, 2020)
"Prostate cancer is a very heterogeneous disease, and contemporary management is focused on identification and treatment of the prognostically adverse high-risk tumors while minimizing overtreatment of indolent, low-risk tumors."2.61Multimodality Imaging of Prostate Cancer. ( Burger, IA; Ghafoor, S; Vargas, AH, 2019)
"Oligorecurrent prostate cancer with exclusive nodal involvement represents a common state of disease, amenable to local therapy."2.61Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row : Nodal oligorecurrent prostate cancer. ( Castellucci, P; Ceci, F; Di Muzio, N; Fodor, A; Hoyer, M; Incerti, E; Ingrosso, G; Jereczek-Fossa, BA; Lancia, A; Ost, P; Picchio, M, 2019)
"Recurrence of prostate cancer is suspected when an increase in the prostate-specific antigen level is detected after radical treatment; the recurrence could be local relapse, distant relapse, or both."2.5311C- or 18F-Choline PET/CT for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer. ( Castellucci, P; Ceci, F; Fanti, S; Incerti, E; Mapelli, P; Picchio, M, 2016)
"PET/CT imaging in men with prostate cancer (PCa) is rapidly growing as clinicians are becoming aware of its possible fundamental role in the diagnostic flow chart of these patients."2.53Rapidly changing landscape of PET/CT imaging in prostate cancer. ( Fanti, S; Hofman, MS; Morigi, JJ; Murphy, D, 2016)
"necrosis in patients with primary brain tumors or brain metastasis."2.53Differentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-Analysis. ( Chen, YC; Chuang, MT; Liu, YS; Tsai, YS; Wang, CK, 2016)
"prostate cancer is the most frequent solid malignant tumor in Western Countries."2.50The role of positron emission tomography/computed tomography imaging with radiolabeled choline analogues in prostate cancer. ( Cózar-Olmo, JM; Gómez-Río, M; Llamas-Elvira, JM; Navarro-Pelayo Láinez, MM; Rodríguez-Fernández, A; Vázquez-Alonso, F, 2014)
"Choline PET/CT has shown limitations for the detection of primary prostate cancer and nodal metastatic disease, mainly due to limited sensitivity and specificity."2.49Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer. ( Gocke, Ch; Hildebrandt, G; Krause, BJ; Kuhnt, T; Kurth, J; Schwarzenböck, SM, 2013)
"In patients with a high risk of distant metastases and suitable for systemic salvage therapy, a positive lesion must be obviously visualized with one of the currently available imaging techniques."2.49The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques? ( Borghesi, M; Brunocilla, E; Castellucci, P; Ceci, F; Fanti, S; Gacci, M; Martorana, G; Nanni, C; Schiavina, R; Vagnoni, V, 2013)
"When MRS and MR imaging agree on prostate cancer presence, the positive predictive value is about 80-90%."2.44Proton MR spectroscopy of the prostate. ( Mueller-Lisse, UG; Scherr, MK, 2007)
"The role of PET imaging in prostate cancer is gradually evolving but still remains within the experimental realm."2.44Is there a role for positron emission tomography imaging in the early evaluation of prostate cancer relapse? ( Cascini, GL; Greco, C; Tamburrini, O, 2008)
"We identified 124 consecutive prostate cancer patients from 2008 to 2018 with a solitary oligorecurrent metastatic lesion on positron emission tomography imaging who were treated with metastasis-directed therapy without androgen deprivation therapy from the Mayo Clinic C-11 choline registry."1.72Metastasis-directed Therapy Without Androgen Deprivation Therapy in Solitary Oligorecurrent Prostate Cancer. ( Ahmed, ME; Andrews, JR; Boorjian, SA; Britton, C; Joshi, VB; Karnes, RJ; Kendi, AT; Kwon, ED; Phillips, R; Sharma, V; Sood, A; Stish, B; Tollefson, MK, 2022)
"Biochemical recurrence of prostate cancer after radiation therapy occurs in 5 to 50% of cases depending on the radiation technique used."1.62Comparison between MRI and choline-PET trans-perineal target biopsies and saturation biopsies for detection and topography of intra-prostatic recurrence after primary radiation therapy for prostate cancer. ( Biscans, C; Chalhoub, K; Debiais-Delpech, C; Guérif, S; Ingrand, P; Raynaud, N; Vallée, M, 2021)
"Chordoid gliomas are extremely rare entities, which are generally considered occurring exclusively in the third ventricle."1.56Chordoid glioma: an entity occurring not exclusively in the third ventricle. ( Du, J; Fang, J; Li, G; Wang, S; Xu, Y; Yang, B; Yang, C, 2020)
"Radiographic changes of brain metastases after stereotactic radiosurgery (SRS) can signify tumor recurrence and/or radiation necrosis (RN); however, standard imaging modalities cannot easily distinguish between these two entities."1.56 ( Beal, K; Beattie, BJ; Blasberg, RG; Brennan, CW; Grkovski, M; Gutin, PH; Humm, JL; Huse, JT; Kohutek, ZA; Rosenblum, MK; Schöder, H; Tabar, VS; Young, RJ; Zanzonico, PB; Zhang, Z, 2020)
"The fluorocholine PET/CT was positive for 81% and negative for 19% of patients."1.56Diagnostic performance of imaging techniques for detecting of local recurrence after prostate brachytherapy. ( Blais, E; Cazeau, AL; De Vaugelade, C; Fontes, F; Hindié, E; Karahissarlian, V; Mariey, A; Petitpierre, F; Rigou, G; Sargos, P; Thomas, L, 2020)
"The response for the 8 prostate cancer-treatment courses was PMD, which correlated well with changes in serum prostatic specific antigen (PSA) (7 of 8 cases showed increased PSA)."1.51Evaluation of Treatment Response in Prostate Cancer and Renal Cell Carcinoma Patients Using 11C-choline PET/CT Findings. ( Fujiwara, M; Go, S; Hashimoto, T; Kaida, H; Kanda, T; Kanematsu, A; Kitajima, K; Nakanishi, Y; Nojima, M; Suzuki, T; Tamaki, Y; Tsurusaki, M; Yamada, Y; Yamakado, K; Yamamoto, S, 2019)
"Reirradiation of patients with prostate cancer who underwent previous radiation therapy is a valuable option that can be safely considered to delay the beginning of hormonal treatment."1.51Reirradiation of Locally Recurrent Prostate Cancer With Volumetric Modulated Arc Therapy. ( Clerici, E; D'Agostino, GR; Di Brina, L; Franceschini, D; Franzese, C; Iftode, C; Mancosu, P; Navarria, P; Scorsetti, M; Tozzi, A, 2019)
"Forty-nine consecutive prostate cancer patients diagnosed with oligometastatic recurrence on Ch-PET have been prospectively treated."1.51Outcomes after a first and/or second salvage treatment in patients with oligometastatic prostate cancer recurrence detected by (18-F) choline PET-CT. ( Ahtamon, A; Bilbao, P; Cacicedo, J; Casquero Ocio, F; Fernandez, I; Garcia-Olaverri, J; Gomez-Iturriaga, A; Llarena, R; Ortiz de Zarate, R; Ost, P; Rodeño, E, 2019)
"38%)."1.51Recurrent prostate cancer after radical prostatectomy: restaging performance of 18F-choline hybrid PET/MRI. ( Achard, V; De Perrot, T; Denis, A; Garibotto, V; Iselin, C; Lamanna, G; Mainta, IC; Miralbell, R; Ratib, O; Zilli, T, 2019)
"Twenty Japanese prostate cancer patients underwent 11C-choline and FDG PET/CT before (n=5) or after (n=15) treatment."1.48Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT in Prostate Cancer. ( Fujiwara, M; Fukushima, K; Hashimoto, T; Kamikonya, N; Kanematsu, A; Kitajima, K; Kobayashi, K; Nakanishi, Y; Nojima, M; Odawara, S; Suzuki, T; Yamada, Y; Yamakado, K; Yamamoto, S, 2018)
"11C-choline-PET/CT-guided HTT is safe and effective in the treatment of LN relapses of prostate cancer in previously treated patients."1.46Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer. ( Berardi, G; Busnardo, E; Calandrino, R; Cozzarini, C; Dell'Oca, I; Di Muzio, NG; Fiorino, C; Fodor, A; Gianolli, L; Incerti, E; Kirienko, M; Mangili, P; Pasetti, M; Picchio, M, 2017)
"Management of recurrent prostate cancer (CaP) after radiotherapy (RT) is dependent on accurate localization of the site of recurrent disease."1.46Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: A Nomogram for Predicting Extrapelvic Disease. ( Boorjian, SA; Choo, R; Davis, BJ; Evans, JD; Gettman, MT; Haloi, R; Harmsen, WS; Karnes, RJ; Kwon, ED; Lowe, VJ; Moreira, DM; Mynderse, LA; Nathan, MA; Olivier, KR; Park, SS; Parker, WP; Sobol, I; Tollefson, MK; Welch, TJ; Zaid, HB, 2017)
"Diagnosis of recurrent hepatocellular carcinoma (HCC) is sometimes challenging, especially when extrahepatic disease is present."1.43Recurrent Extrahepatic Hepatocellular Carcinoma Detected by 18F-Choline PET/CT. ( Geier, A; Götze, O; Lapa, C; Schmid, JS; Weiss, J, 2016)
"Choline PET-CT was positive in 38."1.43A pilot study of the utility of choline PET-CT in prostate cancer biochemical relapse following radical prostatectomy. ( Francis, RJ; Joseph, D; Leong, E; Loh, NK; McCarthy, M; Morandeau, L; Segard, T; Siew, T; Tan, H; Trevenen, M, 2016)
"In two cases history of a second malignancy (lung cancer and cutaneous basocellular carcinoma) was known (diagnosed 12 and 6 years after PCa, respectively)."1.43Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series. ( Boni, R; Castellucci, P; Coraggio, G; Erba, PA; Galeandro, M; Lazzeri, E; Paiar, F; Pasqualetti, F; Perri, M; Roncali, M; Sollini, M; Versari, A, 2016)
"multi-parametric MRI in the prostate cancer relapse."1.42(11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer. ( Cozar, M; Escobar, M; Garcia, JR; Moragas, M; Romera, N; Soler, M, 2015)
"Fifty patients radically treated for prostate cancer and presenting with rising prostate-specific antigen (PSA) levels were consecutively and prospectively enrolled."1.4218F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse: A Comparison to 11C-Choline PET/CT. ( Borghesi, M; Boschi, S; Brunocilla, E; Fanti, S; Martorana, G; Nanni, C; Pettinato, C; Schiavina, R; Zanoni, L, 2015)
"Two patients died of prostate cancer."1.42Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography. ( Bergstralh, EJ; Cheville, JC; DiMonte, G; Karnes, RJ; Kwon, ED; Lowe, VJ; Murphy, CR; Mynderse, LA, 2015)
"Primary therapies for prostate cancer were 19 radical prostatectomy, 18 radiotherapy, 13 radiotherapy with hormonal treatment, 3 brachytherapy."1.42[Biochemical recurrence after curative treatment for localized prostate cancer: Performance of choline PET/CT in the assessment of local recurrence]. ( Arnoux, V; Boillot, B; Carnicelli, D; Descotes, JL; Dubreuil, J; Fiard, G; Lanchon, C; Long, JA; Poncet, D; Rambeaud, JJ; Terrier, N; Verry, C, 2015)
"Lymph node metastasis was present in 32% of resected lymph nodes (681 of 2,122), resulting in 238 positive subregions and 111 positive regions."1.40Detection of lymph node metastasis in patients with nodal prostate cancer relapse using (18)F/(11)C-choline positron emission tomography/computerized tomography. ( Drendel, V; Grosu, AL; Henne, K; Hölz, S; Jandausch, A; Jilg, CA; Krauss, T; Reske, SN; Rischke, HC; Schultze-Seemann, W; Vach, W; Weber, WA; Wieser, G, 2014)
" Genito-urinary (GU) and rectal and bowel toxicity were scored by common terminology criteria for adverse events version 4 (CTCAE V."1.4011C choline PET guided salvage radiotherapy with volumetric modulation arc therapy and hypofractionation for recurrent prostate cancer after HIFU failure: preliminary results of tolerability and acute toxicity. ( Alongi, F; Arturo, C; Ascolese, AM; Bellorofonte, C; Comito, T; Iftode, C; Liardo, RL; Lopci, E; Mancosu, P; Navarria, P; Scorsetti, M; Tomatis, S; Tozzi, A; Villa, E, 2014)
"1%), by requesting 15 frequent items of adverse events from the Common-Terminology-Criteria for Adverse Events Version 4."1.40Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer. ( Grosu, AL; Henne, K; Jilg, CA; Kirste, S; Leifert, A; Rischke, HC; Schlager, D; Schnell, D; Schultze-Seemann, W; Volegova-Neher, N; Wieser, G, 2014)
"The reviewers assessed for local recurrence in the prostatectomy bed as well as LN and bone metastases, rating their diagnostic confidence with a 5-point scoring system for each location."1.40Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil. ( Froemming, AT; Hagen, CE; Kawashima, A; Kitajima, K; Murphy, RC; Nathan, MA; Takahashi, N, 2014)
"Salvage surgery for prostate cancer is a fascinating but controversial approach."1.40First case of 18F-FACBC PET/CT-guided salvage retroperitoneal lymph node dissection for disease relapse after radical prostatectomy for prostate cancer and negative 11C-choline PET/CT: new imaging techniques may expand pioneering approaches. ( Bianchi, L; Borghesi, M; Brunocilla, E; Cevenini, M; Concetti, S; Fanti, S; Gentile, G; Martorana, G; Molinaroli, E; Nanni, C; Schiavina, R, 2014)
"The major outcome measure was disease progression at PET2."1.40Prostate-specific antigen kinetics parameters are predictive of positron emission tomography features worsening in patients with biochemical relapse after prostate cancer treatment with radical intent: Results from a longitudinal cohort study. ( Bartolini, M; Cai, T; Carini, M; Ceroti, M; Detti, B; Gacci, M; Giannì, G; Livi, L; Minervini, A; Pupi, A; Saieva, C; Siena, G; Torshizi, MF, 2014)
"11C-Choline PET was positive in 124/185 cases (65%) (in 22/61 (36%) after RP, 102/124 (82%) after EBRT)."1.39Impact of total PSA, PSA doubling time and PSA velocity on detection rates of 11C-Choline positron emission tomography in recurrent prostate cancer. ( Breeuwsma, AJ; de Jong, IJ; Dierckx, RA; Leliveld, AM; Pruim, J; Rybalov, M, 2013)
"The effectiveness of salvage therapy in prostate cancer is greater for low prostate specific antigen values."1.39[11C]choline positron emission tomography/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigen. ( Briganti, A; Garcia-Parra, R; Gianolli, L; Giovacchini, G; Mapelli, P; Messa, C; Montorsi, F; Picchio, M, 2013)
"On testis removal, a Leydig cell tumor of 2."1.39Incidental detection of Leydig cell tumor via fluorine-18-Choline PET/CT in a patient with recurrent prostate cancer disease. ( Borsatti, E; Cimitan, M; Colletti, PM; Hodolič, M; Maffione, AM; Rubello, D; Urso, C, 2013)
"Recurrent prostate cancer is usually treated by combining radiotherapy and androgen deprivation therapy."1.39Influence of androgen deprivation therapy on choline PET/CT in recurrent prostate cancer. ( Breeuwsma, AJ; de Jong, IJ; Dost, RJ; Glaudemans, AW, 2013)
"[11C]Choline-PET/CT was done within 14 days before SRT."1.38[11C]Choline-PET/CT for outcome prediction of salvage radiotherapy of local relapsing prostate carcinoma. ( Kull, T; Moritz, S; Reske, SN, 2012)
"This supports long-term HT in advanced prostate cancer."1.38Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy. ( Bonomo, P; Clementi, V; D'Agostino, GR; Di Molfetta, IV; Gui, B; Mantini, G; Mattiucci, G; Valentini, AL, 2012)
"Primary brain tumors (PBT), in particular gliomas, are among the most difficult neoplasms to treat, necessitating good quality imaging to guide clinicians at many junctures."1.37Promising role of [18F] fluorocholine PET/CT vs [18F] fluorodeoxyglucose PET/CT in primary brain tumors-early experience. ( Lam, WW; Ng, DC; Ong, SC; See, SJ; Wong, WY; Yu, SW, 2011)
"The histological diagnosis was anaplastic oligodendroglioma (WHO grade III)."1.37[Usefulness of quantitative H-MR spectroscopy for the differentiation between radiation necrosis and recurrence of anaplastic oligodendroglioma]. ( Akutsu, H; Anno, I; Isobe, T; Masumoto, T; Matsumura, A; Nakai, K; Shiigai, M; Takano, S; Yamamoto, T, 2011)
"92 consecutive prostate cancer patients in biochemical progression following radical surgery (63) or radiation treatment (29) were studied with positron emission tomography (PET)."1.35[Usefulness of PET scans in diagnosing recurrent prostate cancer. Prostate with PSA level < 5 ng/ml]. ( Berián Polo, JM; Martínez-Monge, R; Richter, JA; Rincón Mayans, A; Rioja Zuazu, J; Rodríguez, M; Sansi, AS; Zudaire Bergera, JJ, 2009)
"Using discriminant analysis, this study found that MR spectroscopy in combination with ADC ratio, rather than ADC value, can improve the ability to differentiate recurrent glioma and radiation injury."1.34Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging. ( Feng, DC; Li, CF; Liu, H; Zeng, QS; Zhen, JH, 2007)
"In all, 50 patients with prostate cancer who had had initial therapy (radical prostatectomy in 40, external beam radiation in three and interstitial brachytherapy in seven) had PET/CT using [(11)C]-choline in the presence of an increased or increasing prostate-specific antigen (PSA) level."1.34Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer. ( Blumstein, NM; Gschwend, JE; Hautmann, RE; Hohl, K; Kuefer, R; Möller, P; Mottaghy, FM; Reske, SN; Rinnab, L; Wiegel, T, 2007)
"The exact staging of prostate cancer is mandatory to allow selection of the appropriate primary therapy."1.31[The (11C) acetate positron emission tomography in prostatic carcinoma. New prospects in metabolic imaging]. ( Ackermann, R; Coenen, HH; Hautzel, H; Herzog, H; Krause, BJ; Müller-Gärtner, HW; Müller-Mattheis, V; Roden, W, 2002)
"The diagnosis of brain tumors after high-dose radiation therapy is frequently limited by the lack of metabolic discrimination available with conventional imaging methods."1.31Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. ( Chang, S; Dillon, WP; Graves, EE; Larson, D; McDermott, M; Nelson, SJ; Prados, MD; Verhey, L; Vigneron, DB, 2001)
"Necrosis was present histologically in four of the five meningiomas classified either as atypical or papillary."1.30Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy. ( Handa, J; Inubushi, T; Matsuda, M; Morikawa, S; Nakasu, S; Shino, A, 1999)
"Thirteen cases of brain cancer treated by radiation therapy were examined by 1H magnetic resonance spectroscopy and gadolinium-enhanced T1-weighted magnetic resonance imaging and reexamined at 2-month intervals."1.29Hydrogen magnetic resonance spectroscopy follow-up after radiation therapy of human brain cancer. Unexpected inverse correlation between the changes in tumor choline level and post-gadolinium magnetic resonance imaging contrast. ( Levendag, PC; Oudkerk, M; Sijens, PE; van Dijk, P; Vecht, CJ, 1995)
"Surgical specimens of squamous cell carcinoma arising from the upper aerodigestive tract (n = 18) and from muscle (n = 13) were examined in vitro using high-field (11 T) proton MR spectroscopy."1.29Proton MR spectroscopy of squamous cell carcinoma of the upper aerodigestive tract: in vitro characteristics. ( Blackstock, W; Castillo, M; Kwock, L; Mukherji, SK; Schiro, S; Shockley, W; Soper, R; Weissler, M, 1996)
" After oral application He-PC was well absorbed from the intestine and metabolized in the liver by phospholipases C and D."1.28Hexadecylphosphocholine, a new ether lipid analogue. Studies on the antineoplastic activity in vitro and in vivo. ( Breiser, A; Damenz, W; Eibl, H; Engel, J; Fleer, EA; Hilgard, P; Kim, DJ; Nagel, G; Unger, C, 1989)

Research

Studies (236)

TimeframeStudies, this research(%)All Research%
pre-19903 (1.27)18.7374
1990's9 (3.81)18.2507
2000's52 (22.03)29.6817
2010's138 (58.47)24.3611
2020's34 (14.41)2.80

Authors

AuthorsStudies
Zattoni, F2
Artioli, P2
Burei, M1
Chiaravalloti, A2
Chierichetti, F1
Donner, D1
Panareo, S1
Rambaldi, I1
Schillaci, O3
Dal Moro, F1
Evangelista, L7
Albano, D1
Volpi, G1
Dondi, F1
Giubbini, R2
Bertagna, F2
Millard, T1
Sammour, F1
Anthias, C1
Easdale, S1
Gonzalez-Arias, C1
Ethell, M1
Potter, M1
Iyengar, S1
El-Sharkawi, D1
Attygalle, AD1
Chau, I1
Cunningham, D1
Nicholson, E1
Sharma, B1
Feng, A1
Yuan, P2
Huang, T1
Li, L2
Lyu, J1
García Vicente, AM2
Pena Pardo, FJ1
Amo-Salas, M2
Villena Martín, M1
López Menéndez, C1
Soriano Castrejón, ÁM2
Pérez-Beteta, J1
Nyk, Ł1
Kamecki, H1
Krajewski, W1
Małkiewicz, B1
Szydełko, T1
Kubis, M1
Słojewski, M1
Kryst, P1
Poletajew, S1
Malewski, W1
Ma, W1
Mao, J1
Yang, J2
Wang, T1
Zhao, ZH1
Langé, M1
Magné, N3
Zhou, K1
Bellanger, M1
Latorzeff, I1
Pommier, P1
Martin, E2
Paumier, A1
Béra, G1
Supiot, S1
Sandoval Valencia, H1
Lozano Setien, E1
Andrews, JR1
Ahmed, ME1
Sharma, V1
Britton, C1
Stish, B1
Phillips, R1
Kendi, AT1
Joshi, VB1
Sood, A1
Tollefson, MK3
Boorjian, SA2
Karnes, RJ9
Kwon, ED8
Aseel, A1
McCarthy, P1
Mohammed, A1
Sidibe, I1
Tensaouti, F1
Gilhodes, J1
Cabarrou, B1
Filleron, T2
Desmoulin, F1
Ken, S2
Noël, G1
Truc, G1
Sunyach, MP1
Charissoux, M1
Lotterie, JA1
Roques, M1
Péran, P1
Cohen-Jonathan Moyal, E2
Laprie, A4
Urso, L1
Nieri, A1
Borgia, F1
Malorgio, A1
Bartolomei, M1
Sivapathasundaram, A1
Golse, N1
Pascale, A1
Durand, E1
Sebagh, M1
Besson, FL1
Tremblay, S1
Alhogbani, M1
Weickhardt, A1
Davis, ID1
Scott, AM1
Hicks, RJ1
Metser, U1
Chua, S1
Davda, R1
Punwani, S1
Payne, H1
Tunariu, N1
Ho, B1
Young, S1
Singbo, MNU1
Bauman, G2
Emmett, L1
Pouliot, F1
Panagiotidis, E1
Fragkiadaki, V1
Papathanasiou, N1
Kypraios, C1
Liatsikos, E1
Klampatsas, A1
Paschali, A1
Exarhos, D1
Zarokosta, F1
Chatzipavlidou, V1
Apostolopoulos, D1
Datseris, I1
Garrou, F1
Rizzo, A1
Rosso, D1
Bondi, S1
Racca, M1
Yang, B1
Yang, C1
Du, J1
Fang, J1
Li, G1
Wang, S3
Xu, Y2
Kitajima, K3
Yamamoto, S3
Nakanishi, Y2
Yamada, Y2
Hashimoto, T2
Suzuki, T2
Go, S1
Kanematsu, A2
Nojima, M2
Fujiwara, M2
Kaida, H1
Tsurusaki, M1
Kanda, T2
Tamaki, Y1
Yamakado, K2
Ghafoor, S1
Burger, IA2
Vargas, AH1
Grkovski, M1
Kohutek, ZA1
Schöder, H2
Brennan, CW1
Tabar, VS1
Gutin, PH2
Zhang, Z2
Young, RJ1
Beattie, BJ1
Zanzonico, PB1
Huse, JT1
Rosenblum, MK1
Blasberg, RG1
Humm, JL1
Beal, K1
Lovinfosse, P1
Ben Mustapha, S1
Withofs, N1
Walker, SM1
Lim, I1
Lindenberg, L1
Mena, E1
Choyke, PL1
Turkbey, B1
D'Angelillo, RM3
Fiore, M2
Trodella, LE2
Sciuto, R3
Ippolito, E1
Carnevale, A1
Iurato, A1
Miele, M1
Trecca, P1
Trodella, L3
Greco, C2
Ramella, S3
Chandrasekar, T1
Reese, AC1
Olivari, L1
Riccardi, N1
Rodari, P1
Angheben, A1
Salgarello, M1
Karahissarlian, V1
Sargos, P1
Blais, E1
Cazeau, AL1
Fontes, F1
Petitpierre, F1
Rigou, G1
De Vaugelade, C1
Mariey, A1
Hindié, E1
Thomas, L1
Abecassis, JP1
Ghazzar, N1
Peyromaure, M2
Giraud, P1
Nese, M1
Riboli, G1
Brighetti, G1
Sassi, V1
Camela, E1
Caselli, G1
Sassaroli, S1
Borlimi, R1
Aucoin, M1
Cooley, K1
Saunders, PR1
Carè, J1
Anheyer, D1
Medina, DN1
Cardozo, V1
Remy, D1
Hannan, N1
Garber, A1
Velayos, M1
Muñoz-Serrano, AJ1
Estefanía-Fernández, K1
Sarmiento Caldas, MC1
Moratilla Lapeña, L1
López-Santamaría, M1
López-Gutiérrez, JC1
Li, J1
Zhang, J1
Shen, S1
Zhang, B2
Yu, WW1
Toyoda, H1
Huang, DQ1
Le, MH1
Nguyen, MH1
Huang, R1
Zhu, L1
Wang, J6
Xue, L1
Liu, L2
Yan, X2
Huang, S1
Li, Y6
Xu, T1
Li, C2
Ji, F1
Ming, F1
Zhao, Y2
Cheng, J1
Wang, Y3
Zhao, H1
Hong, S1
Chen, K2
Zhao, XA1
Zou, L1
Sang, D1
Shao, H1
Guan, X1
Chen, X2
Chen, Y4
Wei, J1
Zhu, C1
Wu, C1
Moore, HB1
Barrett, CD1
Moore, EE1
Jhunjhunwala, R1
McIntyre, RC1
Moore, PK1
Hajizadeh, N1
Talmor, DS1
Sauaia, A1
Yaffe, MB1
Liu, C3
Lin, Y1
Dong, Y1
Wu, Y1
Bao, Y1
Yan, H2
Ma, J1
Fernández-Cuadros, ME1
Albaladejo-Florín, MJ1
Álava-Rabasa, S1
Usandizaga-Elio, I1
Martinez-Quintanilla Jimenez, D1
Peña-Lora, D1
Neira-Borrajo, I1
López-Muñoz, MJ1
Rodríguez-de-Cía, J1
Pérez-Moro, OS1
Abdallah, M1
Alsaleh, H1
Baradwan, A1
Alfawares, R1
Alobaid, A1
Rasheed, A1
Soliman, I1
Wendel Garcia, PD1
Fumeaux, T1
Guerci, P1
Heuberger, DM1
Montomoli, J2
Roche-Campo, F1
Schuepbach, RA1
Hilty, MP1
Poloni, TE1
Carlos, AF1
Cairati, M1
Cutaia, C1
Medici, V1
Marelli, E1
Ferrari, D1
Galli, A1
Bognetti, P1
Davin, A1
Cirrincione, A1
Ceretti, A1
Cereda, C1
Ceroni, M1
Tronconi, L1
Vitali, S1
Guaita, A1
Leeds, JS1
Raviprakash, V1
Jacques, T1
Scanlon, N1
Cundall, J1
Leeds, CM1
Riva, A1
Gray, EH1
Azarian, S1
Zamalloa, A1
McPhail, MJW1
Vincent, RP1
Williams, R1
Chokshi, S1
Patel, VC1
Edwards, LA1
Alqarawi, W1
Birnie, DH1
Golian, M1
Nair, GM1
Nery, PB1
Klein, A1
Davis, DR1
Sadek, MM1
Neilipovitz, D1
Johnson, CB1
Green, MS1
Redpath, C1
Miller, DC1
Beamer, P1
Billheimer, D1
Subbian, V1
Sorooshian, A1
Campbell, BS1
Mosier, JM1
Novaretti, JV1
Astur, DC1
Cavalcante, ELB1
Kaleka, CC1
Amaro, JT1
Cohen, M1
Huang, W1
Li, T2
Ling, Y1
Qian, ZP1
Zhang, YY1
Huang, D1
Xu, SB1
Liu, XH1
Xia, L1
Yang, Y3
Lu, SH1
Lu, HZ1
Zhang, R2
Ma, JX1
Tang, S1
Li, CM1
Wan, J1
Wang, JF1
Ma, JQ1
Luo, JJ1
Chen, HY2
Mi, SL1
Chen, SY1
Su, YG1
Ge, JB1
Milheiro, SA1
Gonçalves, J1
Lopes, RMRM1
Madureira, M1
Lobo, L1
Lopes, A1
Nogueira, F1
Fontinha, D1
Prudêncio, M1
M Piedade, MF1
Pinto, SN1
Florindo, PR1
Moreira, R1
Castillo-Lora, J1
Delley, MF1
Laga, SM1
Mayer, JM1
Sutjarit, N1
Thongon, N1
Weerachayaphorn, J1
Piyachaturawat, P1
Suksamrarn, A1
Suksen, K1
Papachristou, DJ1
Blair, HC1
Hu, Y1
Shen, P1
Zeng, N1
Wang, L3
Yan, D1
Cui, L1
Yang, K2
Zhai, C1
Yang, M1
Lao, X1
Sun, J2
Ma, N1
Ye, W1
Guo, P1
Rahimi, S1
Singh, MP1
Gupta, J1
Nakanishi, I1
Ohkubo, K1
Shoji, Y1
Fujitaka, Y1
Shimoda, K1
Matsumoto, KI1
Fukuhara, K1
Hamada, H1
van der Boom, T1
Gruppen, EG1
Lefrandt, JD1
Connelly, MA1
Links, TP1
Dullaart, RPF1
Berry, JD1
Bedlack, R1
Mathews, D1
Agnese, W1
Apple, S1
Meloncelli, S1
Divizia, M1
Germani, G1
Adefegha, SA1
Bottari, NB1
Leal, DB1
de Andrade, CM1
Schetinger, MR1
Martínez-Velasco, A1
Perez-Ortiz, AC1
Antonio-Aguirre, B1
Martínez-Villaseñor, L1
Lira-Romero, E1
Palacio-Pastrana, C1
Zenteno, JC1
Ramirez, I1
Zepeda-Palacio, C1
Mendoza-Velásquez, C1
Camacho-Ordóñez, A1
Ortiz Bibriesca, DM1
Estrada-Mena, FJ1
Martin, BL1
Thompson, LC1
Kim, YH2
Snow, SJ1
Schladweiler, MC1
Phillips, P1
Harmon, M1
King, C1
Richards, J1
George, I1
Haykal-Coates, N1
Gilmour, MI1
Kodavanti, UP1
Hazari, MS1
Farraj, AK1
Shen, Z1
Zou, Y1
Gao, K1
Lazar, S1
Wurtzel, JGT1
Ma, P1
Goldfinger, LE1
Vukelic, M1
Laloo, A1
Kyttaris, VC1
Chen, R1
Chen, J2
Xun, J1
Hu, Z1
Huang, Q2
Steinhart, C1
Shen, Y1
Lu, H1
Mansuri, A1
Lokhande, K1
Kore, S1
Gaikwad, S1
Nawani, N1
Swamy, KV1
Junnarkar, M1
Pawar, S1
Shaheen, MY1
Basudan, AM1
Niazy, AA1
van den Beucken, JJJP1
Jansen, JA1
Alghamdi, HS1
Gao, Q2
Guo, X1
Cao, Y1
Jia, X1
Xu, S2
Lu, C2
Zhu, H2
Melku, M1
Abebe, G1
Teketel, A1
Asrie, F1
Yalew, A1
Biadgo, B1
Kassa, E1
Damtie, D1
Anlay, DZ1
Ahmed, MFE1
Ramadan, H1
Seinige, D1
Kehrenberg, C1
Abd El-Wahab, A1
Volkmann, N1
Kemper, N1
Schulz, J1
Hu, MY1
Wu, YN1
McEvoy, MP1
Wang, YF1
Cong, WL1
Liu, LP1
Li, XX1
Zhou, CL1
Chen, WM1
Wei, KL1
Tung, SY1
Shen, CH1
Chang, TS1
Yen, CW1
Hsieh, YY1
Chiu, WN1
Hu, JH1
Lu, SN1
Hung, CH1
Alakavuklar, MA1
Fuqua, C1
Luo, KL1
Underwood, RS1
Greenwald, I1
Elashiry, MM1
Elashiry, M1
Zeitoun, R1
Elsayed, R1
Tian, F1
Saber, SE1
Elashry, SH1
Tay, FR1
Cutler, CW1
O'Dowd, A1
Maciel, M1
Poole, ST1
Jobling, MG1
Rollenhagen, JE1
Woods, CM1
Sincock, SA1
McVeigh, AL1
Gregory, MJ1
Maves, RC1
Prouty, MG1
Holmes, RK1
Savarino, SJ1
Mor, MK1
Palevsky, PM1
Kaufman, JS1
Thiessen Philbrook, H1
Weisbord, SD1
Parikh, CR1
John, CM1
Phillips, NJ1
Jarvis, GA1
Zhu, Y1
Kilburn, S1
Kapoor, M1
Chaturvedi, S1
Shaw, KJ1
Chaturvedi, V1
Kong, X1
Zhang, T1
Xiao, H1
Feng, X1
Tu, H1
Feng, J1
Sabet, M1
Tarazi, Z1
Griffith, DC1
Nguyen, F1
Guan, P1
Guerrero, DT1
Kolla, V1
Naraparaju, K1
Perry, LM1
Soberman, D1
Pressly, BB1
Alferiev, IS1
Chorny, M1
Brodeur, GM1
Gao, X2
Cheng, YH1
Enten, GA1
DeSantis, AJ1
Gaponenko, V1
Majetschak, M1
Kim, DY1
Choi, MJ1
Ko, TK1
Lee, NH1
Kim, OH1
Cheon, HG1
Cai, H1
Yip, V1
Lee, MV1
Wong, S1
Saad, O1
Ma, S1
Ljumanovic, N1
Khojasteh, SC1
Kamath, AV1
Shen, BQ1
Cuypers, ML1
Chanteux, H1
Gillent, E1
Bonnaillie, P1
Saunders, K1
Beckers, C1
Delatour, C1
Dell'Aiera, S1
Ungell, AL1
Nicolaï, J1
Knapp, AK1
Chen, A1
Griffin-Nolan, RJ1
Baur, LE1
Carroll, CJW1
Gray, JE1
Hoffman, AM1
Li, X4
Post, AK1
Slette, IJ1
Collins, SL1
Luo, Y1
Smith, MD1
Temitayo, GI1
Olawande, B1
Emmanuel, YO1
Timothy, AT1
Kehinde, O1
Susan, LF1
Ezra, L1
Joseph, OO1
Lev, S1
Desmarini, D1
Liuwantara, D1
Sorrell, TC1
Hawthorne, WJ1
Djordjevic, JT1
Verso, MG1
Costantino, C1
Marrella, A1
Immordino, P1
Vitale, F1
Amodio, E1
Wang, YD1
Yao, WL1
Xin, ZM1
Han, TT1
Wang, ZG1
Chen, L1
Cai, C1
Zhang, Y4
Ba, D1
Wen, S1
Tian, Q1
Lv, W1
Cheng, G1
Li, N1
Yue, XY1
Chu, WJ1
Chen, Q1
Choi, ES1
Zhao, X3
Zhou, HD1
Sun, XF1
Sharma, S2
Chhoker, S1
Xie, C1
Ong, EWY1
Tan, ZK1
Evans, S1
Weinheimer, CJ1
Kovacs, A1
Williams, JW1
Randolph, GJ1
Jiang, W1
Barger, PM1
Mann, DL1
Liu, J2
Huang, Y1
Kong, L1
Yu, X1
Feng, B1
Liu, D1
Zhao, B1
Mendes, GC1
Ge, D1
Wang, WM1
Fontes, EPB1
Li, P1
Shan, L1
He, P1
Katoh, T1
Sengoku, T1
Hirata, K1
Ogata, K1
Suga, H1
Shun, C1
Yong-Yi, J1
Mei-Li, C1
Shi-Li, L1
Jian-Bo, Z1
Dan-Li, W1
Zhi-Min, G1
Ibrahim, AM1
Zakhary, SY1
Amin, SAW1
Ugurlu, M1
Fornari, VJ1
Hartmann, MSM1
Vanni, JR1
Rodriguez, R1
Langaro, MC1
Pelepenko, LE1
Zaia, AA1
Nakanjako, D1
Zalwango, F1
Wairagala, P1
Luboga, F1
Andia Biraro, I1
Bukirwa, VD1
Mboowa, MG1
Cose, S1
Seeley, J1
Elliott, A1
Zhao, G1
Sun, P1
Hao, S1
Wang, X2
Qu, G1
Xing, Y1
Xu, X1
Maierhofer, M1
Rieger, V1
Mayr, T1
Liu, Y2
Zhang, Q1
Bigliardi, AP1
Fernandes, CLF1
Pinto, EA1
Dos Santos, M1
Garcia, EM1
Baisch, PRM1
Soares, MCF1
Muccillo-Baisch, AL1
da Silva Júnior, FMR1
Yu, W1
Ju, C1
Wang, K1
Zheng, Z1
Liu, H4
Gao, Y1
Martínez-Navarro, EM1
Cebrián-Tarancón, C1
Moratalla-López, N1
Lorenzo, C1
Alonso, GL1
Salinas, RM1
Bermúdez de Castro, JM1
Modesto-Mata, M1
Martín-Francés, L1
García-Campos, C1
Martínez de Pinillos, M1
Martinón-Torres, M1
Hasani, M1
Wu, F2
Warriner, K1
Kurz, M1
Gretzke, D1
Hörlein, R1
Turpault, S1
Atzrodt, J1
Derdau, V1
Yao, Y1
Ou, X1
Zhao, S1
Tian, B1
Jin, S1
Jiang, Z1
Zhou, Z1
Liu, M2
Jiang, GD1
Mou, LH1
Chen, JJ1
Li, ZY1
He, SG1
Reale, E1
Fustinoni, S1
Mercadante, R1
Polledri, E1
Hopf, NB1
Grant, PC1
Levy, K1
Lattimer, TA1
Depner, RM1
Kerr, CW1
Sato, J1
Merenda, MEZ1
Uemoto, AT1
Dos Santos, MP1
Barion, MRL1
Carciofi, AC1
de Paula Dorigam, JC1
Ribeiro, LB1
Vasconcellos, RS1
Waller, SB1
Peter, CM1
Hoffmann, JF1
Cleff, MB1
Faria de, RO1
Zani, JL1
Martins, BA1
Sande, D1
Solares, MD1
Takahashi, JA1
Yang, S2
Jia, Y1
Yin, C1
Zhao, R1
Ojha, M1
Wu, B1
Deepa, M1
Mo, J1
Au, DW1
Wan, MT1
Shi, J1
Zhang, G1
Winkler, C1
Kong, RY1
Seemann, F1
Bianco, M1
Calvano, CD1
Ventura, G1
Bianco, G1
Losito, I1
Cataldi, TRI1
Angiolella, L1
Staudt, A1
Duarte, PF1
Amaral, BPD1
Peixoto Andrade, BCO1
Simas, NK1
Correa Ramos Leal, I1
Sangenito, LS1
Santos, ALSD1
de Oliveira, D1
Junges, A1
Cansian, RL1
Paroul, N1
Siu, J1
Klingler, L1
Hung, CT1
Jeong, SH1
Smith, S1
Tingle, MD1
Wagner Mackenzie, B1
Biswas, K1
Douglas, RG1
Oza, AM1
Lorusso, D1
Aghajanian, C1
Oaknin, A1
Dean, A1
Colombo, N1
Weberpals, JI1
Clamp, AR1
Scambia, G1
Leary, A1
Holloway, RW1
Gancedo, MA1
Fong, PC1
Goh, JC1
O'Malley, DM1
Armstrong, DK1
Banerjee, S1
García-Donas, J1
Swisher, EM1
Cella, D1
Meunier, J1
Goble, S1
Cameron, T1
Maloney, L1
Mörk, AC1
Bedel, J1
Ledermann, JA1
Coleman, RL1
Vlek, SL1
Burm, R1
Govers, TM1
Vleugels, MPH1
Tuynman, JB1
Mijatovic, V1
Leicht, AS1
Connor, J1
Conduit, N1
Vaquera, A1
Gómez, MA1
McKay, JA1
Church, AL1
Rubin, N1
Emory, TH1
Hoven, NF1
Kuehn-Hajder, JE1
Nelson, MT1
Ramanna, S1
Auerbach, EJ1
Moeller, S1
Bolan, PJ1
Fox, NP1
Leonard, M1
Sjerps, MJ1
Chang, EF1
Hyun, S1
Saejio, A1
Shanmugam, S1
Liu, X1
Sun, M1
Bai, Z1
Jaque-Fernandez, F1
Beaulant, A1
Berthier, C1
Monteiro, L1
Allard, B1
Casas, M1
Rieusset, J1
Jacquemond, V1
Góngora-García, OR1
Aca-Aca, G1
Baz-Rodríguez, SA1
Monte, A1
Maganaris, C1
Baltzopoulos, V1
Zamparo, P1
Wang, Z2
Hou, Y1
Cai, L1
Tu, YJ1
Tan, B1
Jiang, L1
Wu, ZH1
Yu, HJ1
Li, XQ1
Yang, AD1
Titze, IR1
Palaparthi, A1
Mau, T1
González, MA1
Goiri, F1
Barandika, JF1
García-Pérez, AL1
Jatt, LP1
Gandhi, MM1
Guo, R1
Sukhija-Cohen, A1
Bhattacharya, D1
Tseng, CH1
Chew, KW1
Onwumere, J1
Pia Tek, J1
Budnyak, T1
Budnyk, S1
Karim, Z1
Thersleff, T1
Kuśtrowski, P1
Mathew, AP1
Slabon, A1
Guo, M1
Zhao, T1
Xing, Z1
Qiu, Y1
Pan, K1
Li, Z2
Zhou, W1
Ghassemi Tabrizi, S1
Arbuznikov, AV1
Jiménez-Hoyos, CA1
Kaupp, M1
Lin, MH2
Bulman, DM1
Remucal, CK1
Chaplin, BP1
Laguerre, A1
George, LA1
Gall, ET1
Emerson, MS1
Wang, H4
Maginn, EJ1
Margulis, CJ1
Li, H2
Feng, W1
Kang, X2
Yan, S1
Chao, M1
Mo, S1
Sun, W1
Lu, Y2
Chen, C1
Stevens, DM1
Adiseshaiah, P1
Dasa, SSK1
Potter, TM1
Skoczen, SL1
Snapp, KS1
Cedrone, E1
Patel, N1
Busman-Sahay, K1
Rosen, EP1
Sykes, C1
Cottrell, M1
Dobrovolskaia, MA1
Estes, JD1
Kashuba, ADM1
Stern, ST1
Özütemiz, C1
Neil, EC1
Tanwar, M1
Rubin, NT1
Ozturk, K1
Cayci, Z1
Duscha, BD1
Kraus, WE1
Jones, WS1
Robbins, JL1
Piner, LW1
Huffman, KM1
Allen, JD1
Annex, BH1
Mehmood, T1
Ahmad, I1
Bibi, S1
Mustafa, B1
Ali, I1
Dahal, RH1
Chaudhary, DK1
Kim, DU1
Kim, J1
Yeter, HH1
Gonul, I1
Guz, G1
Helvaci, O1
Korucu, B1
Akcay, OF1
Derici, U1
Arinsoy, T1
Neffati, R1
Judeinstein, P1
Rault, J1
Chai, X1
Ren, T1
Yu, S1
Fu, Q2
Ye, J1
Ge, X1
Song, J1
Yang, H2
El-Baba, TJ1
Lutomski, CA1
Kantsadi, AL1
Malla, TR1
John, T1
Mikhailov, V1
Bolla, JR1
Schofield, CJ1
Zitzmann, N1
Vakonakis, I1
Robinson, CV1
Langham, MC1
Caporale, AS1
Wehrli, FW1
Parry, S1
Schwartz, N1
den Boer, RB1
Jones, KI1
Ash, S1
van Boxel, GI1
Gillies, RS1
O'Donnell, T1
Ruurda, JP1
Sgromo, B1
Silva, MA1
Maynard, ND1
Sivieri, EM1
Eichenwald, EC1
Rub, D1
Abbasi, S1
Krahnert, I1
Bolze, A1
Gibon, Y1
Fernie, AR1
Huang, L1
Wan, Y1
Dang, Z1
Yang, P1
Yang, Q1
Wu, S2
Lin, CC1
Hsu, CT1
Liu, W2
Huang, SC1
Kortz, U1
Mougharbel, AS1
Chen, TY1
Hu, CW1
Lee, JF1
Wang, CC1
Liao, YF1
Li, LJ1
Peng, S1
Stimming, U1
Hebbar Kannur, K1
Yaqub, TB1
Pupier, C1
Héau, C1
Cavaleiro, A1
Ono, A1
Matsui, J1
Hoshino, N1
Akutagawa, T1
Miyashita, T1
Mitsuishi, M1
Patel, SM1
Smith, TG1
Morton, M1
Stiers, KM1
Seravalli, J1
Mayclin, SJ1
Edwards, TE1
Tanner, JJ1
Becker, DF1
Butcher, TW1
Yang, JL1
Hartwig, JF1
Yu, MF1
Xia, ZZ1
Yao, JC1
Feng, Z1
Li, DH1
Liu, T1
Cheng, GJ1
He, DL1
Li, XH1
Huurman, R1
Schinkel, AFL1
de Jong, PL1
van Slegtenhorst, MA1
Hirsch, A1
Michels, M1
Kataja, A1
Tarvasmäki, T1
Lassus, J1
Sionis, A1
Mebazaa, A1
Pulkki, K1
Banaszewski, M1
Carubelli, V1
Hongisto, M1
Jankowska, E1
Jurkko, R1
Jäntti, T1
Kasztura, M1
Parissis, J1
Sabell, T1
Silva-Cardoso, J1
Spinar, J1
Tolppanen, H1
Harjola, VP1
Carsetti, A1
Damiani, E1
Casarotta, E1
Scorcella, C1
Domizi, R1
Gasparri, F1
Gabbanelli, V1
Pantanetti, S1
Carozza, R1
Adrario, E1
Donati, A1
Almada, E1
Pariani, A1
Rivabella Maknis, T1
Hidalgo, F1
Vena, R1
Favre, C1
Larocca, MC1
Lu, ZY1
Jiang, WD1
Wu, P1
Kuang, SY1
Tang, L1
Zhou, XQ1
Feng, L1
Leal, M1
Zampini, IC1
Mercado, MI1
Moreno, MA1
Simirgiotis, MJ1
Bórquez, J1
Ponessa, G1
Isla, MI1
Saliu, IO1
Amoo, ZA1
Khan, MF1
Olaleye, MT1
Rema, V1
Akinmoladun, AC1
Khan, AU1
Rahman, AU1
Yuan, Q1
Ahmad, A1
Khan, ZUH1
Mahnashi, MH1
Alyami, BA1
Alqahtani, YS1
Ullah, S1
Wirman, AP1
Gao, M1
Deng, L1
Zhang, K2
Wang, M1
Xia, Z1
Gao, D1
Balkissou, AD1
Poka-Mayap, V1
Massongo, M1
Djenabou, A1
Endale-Mangamba, LM1
Olomo, EJ1
Boulleys-Nana, JR1
Diffo-Sonkoue, L1
Adidigue-Ndiome, R1
Alexandra, AJE1
Haman-Wabi, AB1
Adama, S1
Iddi-Faical, A1
Pefura-Yone, EW1
Zhao, Q1
Tong, W1
Ge, C1
Zhao, D1
Norbäck, D1
Li, B1
Zhao, Z1
Huang, C1
Zhang, X1
Qian, H1
Yang, X1
Sun, Y1
Sundell, J1
Deng, Q1
Kim, HJ1
Jeon, JW1
Hwang, SM1
Chu, KI1
Cha, YH1
Kwak, YD1
Choi, SD1
Aslam, M1
Kim, CG1
Zhou, J1
Yang, E1
Yang, W1
Alongi, P2
Stefano, A1
Comelli, A1
Laudicella, R1
Scalisi, S1
Arnone, G1
Barone, S1
Spada, M1
Purpura, P1
Bartolotta, TV1
Midiri, M1
Lagalla, R1
Russo, G1
Gravis, G1
Autret, A1
Guibert-Broudic, M1
Dubergé, T1
Zemmour, C1
Carrier, P1
Salem, N1
Badinand, D1
Cartier, L1
Gross, E1
Walz, J1
Pignot, G1
Brenot-Rossi, I1
Taralli, S1
Cocciolillo, F1
Alitto, AR1
Caldarella, C1
Giacomuzzi, F1
Di Gregorio, F1
Rensi, M1
Cassarino, G1
Lauro, A1
Morlacco, A1
Sepulcri, M1
Nguyen, AAL1
Ietto, F1
Cecchin, D1
Lacognata, C1
Zucchetta, P1
Biscans, C1
Vallée, M1
Ingrand, P1
Debiais-Delpech, C1
Raynaud, N1
Chalhoub, K1
Guérif, S1
Kanoun, S2
Walker, P1
Vrigneaud, JM1
Depardon, E1
Barbier, V1
Humbert, O2
Moulin, M1
Créhange, G3
Cormier, L4
Loffroy, R1
Brunotte, F3
Cochet, A4
Puche-Sanz, I2
Triviño-Ibáñez, E1
Vázquez-Alonso, F2
Llamas-Elvira, JM3
Cózar-Olmo, JM2
Rodríguez-Fernández, A3
Lawrentschuk, N1
Corfield, JM1
Scott, A1
Nehra, A1
Parker, WP4
Haloi, R3
Park, SS3
Mynderse, LA6
Lowe, VJ7
Davis, BJ5
Quevedo, JF1
Johnson, GB1
Incerti, E6
Gangemi, V1
Mapelli, P5
Deantoni, CL1
Giovacchini, G7
Fallanca, F1
Fodor, A5
Ciarmiello, A2
Baldari, S1
Gianolli, L7
Di Muzio, N5
Picchio, M12
El Kabbaj, O1
Robin, P1
Bourhis, D1
Dissaux, G1
Rosenfelder, N1
Valeri, A1
Fournier, G1
Salaun, PY1
Pradier, O1
Malhaire, JP1
Abgral, R1
Schick, U1
Lorca, AM1
Ghedini, P1
Bossert, I1
Zanoni, L3
Ceci, F7
Graziani, T3
Castellucci, P11
Ambrosini, V3
Massari, F1
Nobili, E1
Melotti, B1
Musto, A1
Zoboli, S1
Antunovic, L2
Kirienko, M3
Chiti, A2
Mosconi, C1
Ardizzoni, A2
Golfieri, R1
Fanti, S15
Nanni, C9
Li, R1
Ravizzini, GC1
Gorin, MA1
Maurer, T1
Eiber, M3
Cooperberg, MR1
Alemozzaffar, M1
Delacroix, SE1
Chapin, BF1
Gillebert, Q1
Huchet, V3
Rousseau, C2
Olivier, P1
Courbon, F1
Gontier, E1
Nataf, V2
Balogova, S3
Talbot, JN3
Gafita, A1
Müller, J1
Kranzbühler, B1
Donati, OF1
Eberli, D1
Giovannini, E1
Cozzarini, C3
Frood, R1
Baren, J1
McDermott, G1
Bottomley, D1
Patel, C1
Scarsbrook, A1
Lancia, A1
Hoyer, M1
Jereczek-Fossa, BA4
Ost, P2
Ingrosso, G1
Odawara, S1
Kobayashi, K1
Kamikonya, N1
Fukushima, K1
Linxweiler, J1
Saar, M1
Al-Kailani, Z1
Janssen, M1
Ezziddin, S1
Stöckle, M1
Siemer, S1
Ohlmann, CH1
Sathianathen, NJ1
Butaney, M1
Konety, BR1
Gao, L1
Xu, W1
Zheng, J1
Chen, G1
Samper Ots, P1
Luis Cardo, A1
Vallejo Ocaña, C1
Cabeza Rodríguez, MA1
Glaria Enríquez, LA1
Couselo Paniagua, ML1
Olivera Vegas, J1
Barbaud, M1
Frindel, M1
Ferrer, L1
Le Thiec, M1
Rusu, D1
Rauscher, A1
Maucherat, B1
Baumgartner, P1
Fleury, V1
Colombié, M1
Thierry-Morel, A1
Kraeber-Bodéré, F1
Campion, L1
Triviño-Ibáñez, EM1
Gómez-Río, M2
Cózar Olmo, JM1
D'Agostino, GR2
Di Brina, L1
Mancosu, P2
Franzese, C1
Iftode, C2
Franceschini, D1
Clerici, E1
Tozzi, A2
Navarria, P2
Scorsetti, M2
Witkowska-Patena, E1
Giżewska, A1
Miśko, J1
Dziuk, M1
Gomez-Iturriaga, A1
Casquero Ocio, F1
Fernandez, I1
Rodeño, E1
Llarena, R1
Garcia-Olaverri, J1
Ortiz de Zarate, R1
Cacicedo, J1
Ahtamon, A1
Bilbao, P1
Achard, V1
Lamanna, G1
Denis, A1
De Perrot, T1
Mainta, IC1
Ratib, O4
Iselin, C1
Miralbell, R6
Garibotto, V2
Zilli, T3
Babu, MA1
Spinner, RJ1
Dyck, PJ1
Amrami, KK1
Nathan, MA5
Kawashima, A2
Howe, BM1
Dost, RJ1
Glaudemans, AW1
Breeuwsma, AJ4
de Jong, IJ6
Schwarzenböck, SM2
Kurth, J2
Gocke, Ch1
Kuhnt, T1
Hildebrandt, G1
Krause, BJ5
Schiavina, R9
Boschi, S2
Pettinato, C3
Brunocilla, E7
Martorana, G6
Borghesi, M4
Vagnoni, V2
Gacci, M2
Ratai, EM1
Snyder, BS1
Boxerman, JL1
Safriel, Y1
McKinstry, RC1
Bokstein, F1
Gilbert, MR1
Sorensen, AG1
Barboriak, DP1
Passoni, NM1
Suardi, N3
Abdollah, F2
Messa, C6
Freschi, M2
Montorsi, F6
Briganti, A6
Mamede, M1
Fuccio, C3
Fantini, L1
Costa, S1
Ferretti, A1
Colletti, PM2
Rubello, D5
Cimitan, M3
Hodolič, M3
Maffione, AM1
Borsatti, E3
Urso, C1
Alongi, F2
Liardo, RL1
Lopci, E2
Villa, E1
Comito, T1
Ascolese, AM1
Tomatis, S1
Bellorofonte, C1
Arturo, C1
Hausmann, D1
Bittencourt, LK1
Attenberger, UI1
Sertdemir, M1
Weidner, A1
Büsing, KA1
Brade, J1
Wenz, F1
Schoenberg, SO1
Dinter, DJ1
Buchegger, F3
Allainmat, L1
Jorcano, S1
Vees, H4
Rager, O1
Steiner, C2
Zaidi, H4
Seimbille, Y1
Gentile, G2
Romagnoli, D1
Fabbri, C1
Galassi, R1
Moretti, A1
Sintuzzi, E1
Mautone, V1
Sarti, G1
Strigari, L1
Benassi, M1
Matteucci, F1
Cai, T1
Siena, G1
Minervini, A1
Torshizi, MF1
Bartolini, M1
Giannì, G1
Saieva, C1
Ceroti, M1
Detti, B1
Livi, L1
Pupi, A2
Carini, M1
Takenaka, S1
Asano, Y1
Shinoda, J1
Nomura, Y1
Yonezawa, S1
Miwa, K1
Yano, H1
Iwama, T1
Concetti, S1
Cevenini, M1
Bianchi, L1
Molinaroli, E1
Garcia-Parra, R2
Schindler, C1
Fazio, F2
Murphy, RC1
Froemming, AT2
Hagen, CE1
Takahashi, N1
Calabria, F1
Jilg, CA3
Schultze-Seemann, W2
Drendel, V1
Vach, W1
Wieser, G2
Krauss, T2
Jandausch, A1
Hölz, S1
Henne, K3
Reske, SN7
Grosu, AL3
Weber, WA1
Rischke, HC3
Navarro-Pelayo Láinez, MM1
Lépinoy, A1
Cueff, A1
Maingon, P1
Bosset, JF1
De Bari, B1
Lestrade, L1
Giammarile, F1
Piccardo, A2
Paparo, F2
Piccazzo, R2
Picazzo, R1
Naseri, M1
Ricci, P1
Marziano, A1
Bacigalupo, L2
Biscaldi, E1
Rollandi, GA2
Grillo-Ruggieri, F1
Farsad, M1
Mazzarotto, R1
Celli, M1
Lodi, F3
Muruganandham, M1
Clerkin, PP1
Smith, BJ1
Anderson, CM1
Morris, A1
Capizzano, AA1
Magnotta, V1
McGuire, SM1
Smith, MC1
Bayouth, JE1
Buatti, JM1
Papalia, R2
Gallucci, M2
Maini, CL2
Deviers, A1
Rowland, B1
Laruelo, A1
Catalaa, I2
Lubrano, V1
Celsis, P1
Berry, I2
Mogicato, G1
Leifert, A1
Schnell, D1
Kirste, S1
Volegova-Neher, N2
Schlager, D1
Murphy, CR1
Bergstralh, EJ1
DiMonte, G1
Cheville, JC1
Li, W1
Ma, L1
Hu, X1
Walker, PM1
Beheshti, M2
Kunit, T1
Haim, S1
Zakavi, R1
Schiller, C1
Stephens, A1
Dinkelborg, L1
Langsteger, W1
Loidl, W1
Goldstein, J1
Even-Sapir, E1
Ben-Haim, S1
Saad, A1
Spieler, B1
Davidson, T1
Berger, R1
Weiss, I1
Appel, S1
Lawrence, YR1
Symon, Z1
Gakis, G1
Stenzl, A2
Garcia, JR1
Romera, N1
Cozar, M1
Soler, M1
Moragas, M1
Escobar, M1
Oyen, WJ1
Mariani, G1
Baseric, T2
Bodanza, V1
Saladini, G1
Volterrani, D1
Cervino, AR1
Gregianin, M1
Puccini, G1
Guidoccio, F1
Fettich, J2
Simone, G1
Di Pierro, GB1
Rea, S1
Ferriero, M1
Guaglianone, S1
Romagnoli, A1
Monticone, M1
Cevasco, L1
Campodonico, F1
Conzi, GM1
Carmignani, G1
Renard-Penna, R1
Michaud, L1
Bastide, C1
Beuzeboc, P1
Fromont, G1
Hennequin, C2
Mongiat-Artus, P2
Rozet, F1
Richaud, P1
Salomon, L1
Soulié, M1
Poncet, D1
Arnoux, V1
Descotes, JL1
Rambeaud, JJ1
Verry, C1
Terrier, N1
Boillot, B1
Dubreuil, J1
Lanchon, C1
Carnicelli, D1
Fiard, G1
Long, JA1
Stadlbauer, A1
Pichler, P1
Karl, M1
Brandner, S1
Lerch, C1
Renner, B1
Heinz, G1
Kjölhede, H1
Ahlgren, G1
Almquist, H1
Liedberg, F1
Lyttkens, K1
Ohlsson, T1
Bratt, O1
Winter, A1
Henke, RP1
Wawroschek, F1
Quero, L1
Vercellino, L1
de Kerviler, E1
Culine, S1
Merlet, P1
Ravery, V1
Meria, P1
Desgrandchamps, F1
Di Biagio, D1
Tavolozza, M1
Abbatiello, P1
Tolia, M1
Verganelakis, D1
Tsoukalas, N1
Kyrgias, G1
Papathanasiou, M1
Mosa, E1
Kokakis, I1
Kouvaris, JR1
Pissakas, G1
Pistevou-Gombaki, K1
Kelekis, N1
Kouloulias, V1
Fiorino, C2
Busnardo, E2
Wahart, A1
Guy, JB1
Vallard, A1
Geissler, B1
Ben Mrad, M1
Falk, AT1
Prevot, N1
de Laroche, G1
Rancoule, C1
Chargari, C1
Chuang, MT1
Liu, YS1
Tsai, YS1
Chen, YC1
Wang, CK1
Eiberger, AK1
Lapa, C2
Schmid, JS1
Weiss, J1
Geier, A1
Götze, O1
Hegemann, NS1
Wenter, V1
Spath, S1
Kusumo, N1
Li, M1
Bartenstein, P1
Fendler, WP1
Stief, C2
Belka, C1
Ganswindt, U2
Bluemel, C1
Krebs, M1
Polat, B1
Linke, F1
Samnick, S1
Lassmann, M1
Riedmiller, H1
Czernin, J1
Bley, T1
Kropf, S1
Wester, HJ1
Buck, AK3
Herrmann, K1
Rybalov, MA1
De Iong, IY1
Breusma, AI1
Al'-Shukri, SKh1
Borovets, SY1
Tan, H1
Joseph, D1
Loh, NK1
McCarthy, M1
Leong, E1
Siew, T1
Segard, T1
Morandeau, L2
Trevenen, M1
Francis, RJ1
Berardi, G1
Dell'Oca, I1
Mangili, P1
Pasetti, M1
Calandrino, R1
Di Muzio, NG1
Polverari, G1
Lima, GM1
Morganti, AG1
Lapa, P1
Silva, R1
Saraiva, T1
Figueiredo, A1
Ferreira, R1
Costa, G1
Lima, JP1
Sobol, I2
Zaid, HB2
Morigi, JJ1
Murphy, D1
Hofman, MS1
Novara, G1
Lowe, V1
Knieling, A1
Souvatzoglou, M2
Steiger, K1
Esposito, I1
Retz, M1
Kübler, H1
Gschwend, JE2
Schwaiger, M2
Thalgott, M1
Sollini, M1
Pasqualetti, F1
Perri, M1
Coraggio, G1
Roncali, M1
Boni, R1
Lazzeri, E1
Galeandro, M1
Paiar, F1
Versari, A1
Erba, PA1
Olivier, KR1
Choo, R2
Welch, TJ1
Evans, JD2
Harmsen, WS1
Moreira, DM1
Gettman, MT1
Conde-Moreno, AJ1
Herrando-Parreño, G1
Muelas-Soria, R1
Ferrer-Rebolleda, J1
Broseta-Torres, R1
Cozar-Santiago, MP1
García-Piñón, F1
Ferrer-Albiach, C1
Bossi, A1
Mottet, N1
Blanchard, P1
Couñago, F1
Recio, M1
Maldonado, A1
Del Cerro, E1
Díaz-Gavela, AA1
Thuissard, IJ1
Sanz-Rosa, D1
Marcos, FJ1
Olaciregui, K1
Mateo, M1
Cerezo, L1
Gandaglia, G1
Fossati, N1
Stish, BJ1
Olivier, K1
Welch, BT1
Pisansky, TM1
Nakagomi, K2
Goto, S2
Torizuka, T3
Rinnab, L3
Mottaghy, FM3
Simon, J2
Volkmer, BG1
de Petriconi, R1
Hautmann, RE3
Wittbrodt, M1
Egghart, G1
Moeller, P1
Blumstein, N1
Reske, S1
Kuefer, R2
Booth, SJ1
Pickles, MD1
Turnbull, LW1
Smith, EA2
Carlos, RC2
Junck, LR1
Tsien, CI1
Elias, A1
Sundgren, PC3
Steiner, Ch1
Wissmeyer, M2
Berrebi, O1
Kossovsky, MP1
Khan, HG1
Cronauer, MV1
Hohl, K2
Richter, JA2
Rodríguez, M2
Rioja, J1
Peñuelas, I1
Martí-Climent, J1
Garrastachu, P1
Quincoces, G1
Zudaire, J1
García-Velloso, MJ1
Santi, I1
Rizzello, A1
Franceschelli, A1
Manferrari, F1
Senthamizhchelvan, S1
Pruim, J4
van den Bergh, AC1
Leliveld, AM3
Nijman, RJ1
Dierckx, RA3
Matsusue, E1
Fink, JR1
Rockhill, JK1
Ogawa, T1
Maravilla, KR1
Rioja Zuazu, J1
Rincón Mayans, A1
Sansi, AS1
Zudaire Bergera, JJ1
Martínez-Monge, R1
Berián Polo, JM1
Goenka, AH1
Kumar, A1
Sharma, R1
Kirilova, A1
Damyanovich, A1
Crook, J1
Jezioranski, J1
Wallace, K1
Pintilie, M1
Scattoni, V2
Salonia, A1
Landoni, C1
Rigatti, P2
Heidenreich, A2
Thalmann, GN1
Lam, WW1
Ng, DC1
Wong, WY1
Ong, SC1
Yu, SW1
See, SJ1
Parekh, C1
Jubran, R1
Erdreich-Epstein, A1
Panigrahy, A1
Bluml, S1
Finlay, J1
Dhall, G1
Bossi Zanetti, I1
Zerini, D2
Orecchia, R2
Beltramo, G1
Fariselli, L1
Fodor, C1
Santoro, L1
Vavassori, A1
Gherardi, F1
Ascione, C1
Bossi-Zanetti, I1
Mauro, R1
Bregantin, A1
Bianchi, LC1
De Cobelli, O1
Panebianco, V1
Sciarra, A1
Lisi, D1
Galati, F1
Buonocore, V1
Catalano, C1
Gentile, V1
Laghi, A1
Passariello, R1
Muacevic, A1
Kufeld, M1
Rist, C1
Wowra, B1
Staehler, M1
Isobe, T1
Akutsu, H1
Yamamoto, T1
Shiigai, M1
Masumoto, T1
Nakai, K1
Takano, S1
Anno, I1
Matsumura, A1
Pürschel, A1
Thamm, R1
Schuster, T1
Zimmermann, F1
Molls, M1
Geinitz, H1
Zengerling, F1
Schrader, AJ1
Schrader, M1
Jentzmik, F1
Abuhilal, M1
Bosio, G1
Simeone, C1
Rossini, P1
Pizzocaro, C1
Orlando, E1
Finamanti, M1
Biasiotto, G1
Rodella, C1
Cosciani Cunico, S1
Elias, AE1
Frechtling, D1
George, B1
Maly, P2
Lavrnic, S1
Macvanski, M1
Ristic-Balos, D1
Gavrilov, M1
Damjanovic, D1
Gavrilovic, S1
Milicevic, M1
Skender-Gazibara, M1
Stosic-Opincal, T1
Belhocine, T1
Kovacs, M1
Ward, A1
Rachinsky, I1
Rietbergen, DD1
van der Hiel, B1
Vogel, W1
Stokkel, MP1
Rodari, M1
Pepe, G1
Rybalov, M2
Rosati, S1
Veltman, NC1
Valentini, AL1
Gui, B1
Mattiucci, G1
Clementi, V1
Di Molfetta, IV1
Bonomo, P1
Mantini, G1
Olbert, PJ1
Heinis, J1
Hofmann, R1
Hegele, A1
Fartoux, L1
Kerrou, K2
Rosmorduc, O1
Guidalotti, PL1
Gavaruzzi, G1
Montini, GC1
Marzola, MC1
Henninger, B1
Vesco, P1
Putzer, D1
Kendler, D1
Loizides, A1
Bale, RJ1
Virgolini, IJ1
Moritz, S1
Kull, T1
Mitchell, CR1
Rangel, LJ1
Hung, JC1
Rock, JP1
Hearshen, D1
Scarpace, L1
Croteau, D1
Gutierrez, J1
Fisher, JL1
Rosenblum, ML1
Mikkelsen, T1
Rabinov, JD1
Lee, PL1
Barker, FG1
Louis, DN1
Harsh, GR1
Cosgrove, GR1
Chiocca, EA1
Thornton, AF1
Loeffler, JS1
Henson, JW1
Gonzalez, RG1
Hautzel, H1
Müller-Mattheis, V1
Herzog, H1
Roden, W1
Coenen, HH1
Ackermann, R1
Müller-Gärtner, HW1
Elsinga, PH1
Vaalburg, W1
Mensink, HJ1
Mueller-Lisse, UG2
Scherr, M1
Kanno, T1
Futatsubashi, M2
Okada, H1
Yoshikawa, E1
Nakamura, F1
Takekuma, M1
Maeda, M1
Ouchi, Y1
Lichy, MP2
Bachert, P2
Henze, M1
Lichy, CM1
Debus, J2
Schlemmer, HP3
Ando, K1
Ishikura, R1
Nagami, Y1
Morikawa, T1
Takada, Y1
Ikeda, J1
Nakao, N1
Matsumoto, T1
Arita, N1
Chan, AA1
Lau, A1
Pirzkall, A2
Chang, SM2
Verhey, LJ1
Larson, D3
McDermott, MW1
Dillon, WP5
Nelson, SJ5
Plotkin, M1
Eisenacher, J1
Bruhn, H1
Wurm, R1
Michel, R1
Stockhammer, F1
Feussner, A1
Dudeck, O1
Wust, P1
Felix, R1
Amthauer, H1
Raizer, JJ1
Koutcher, JA1
Abrey, LE1
Panageas, KS1
DeAngelis, LM1
Lis, E1
Zakian, KL1
Yoshida, S1
Haas-Kogan, DA1
Cha, S1
Banerjee, A1
Le, TP1
Nelson, S1
McKnight, TR2
Weybright, P1
Hassan, DG1
Nan, B1
Rohrer, S1
Junck, L1
Kwee, SA1
Wei, H1
Sesterhenn, I1
Yun, D1
Coel, MN1
Hamprecht, F1
Weber, MA1
Schulz-Ertner, D1
Kauczor, HU1
Zeng, QS2
Li, CF2
Zhen, JH2
Feng, DC1
Bochner, B1
Oyama, N1
Roscigno, M1
Da Pozzo, L1
Bocciardi, A1
Albrecht, S1
Khan, H1
Husarik, D1
Soloviev, D1
Hany, TF1
Gutman, F1
Kerrouche, N1
Montravers, F1
Grahek, D1
Cussenot, O1
Gattegno, B1
Thibault, P1
Kotzerke, J1
Zöphel, K1
Salomon, G1
Graefen, M1
Kang, XS1
Scherr, MK1
Blumstein, NM2
Möller, P1
Wiegel, T1
Glatting, G1
Lenzo, NP1
Anderson, J1
Campbell, A1
De Grado, TR1
Cascini, GL1
Tamburrini, O1
Cassol, E1
Berchery, D1
Marre, D1
Bachaud, JM1
Moyal, EC1
Schilling, D1
Wagner, PH1
Böttcher, P1
Merseburger, AS1
Aschoff, P1
Bares, R1
Pfannenberg, C1
Corvin, S1
Pelosi, E1
Arena, V1
Skanjeti, A1
Pirro, V1
Douroukas, A1
Mancini, M1
Sijens, PE1
Vecht, CJ1
Levendag, PC1
van Dijk, P1
Oudkerk, M1
Mukherji, SK1
Schiro, S1
Castillo, M1
Kwock, L1
Soper, R1
Blackstock, W1
Shockley, W1
Weissler, M1
Tedeschi, G1
Lundbom, N1
Raman, R1
Bonavita, S1
Duyn, JH1
Alger, JR2
Di Chiro, G1
Wald, LL2
Day, MR2
Noworolski, SE1
Henry, RG2
Huhn, SL1
Chang, S3
Prados, MD3
Sneed, PK2
Larson, DA1
Wara, WM1
McDermott, M3
Vigneron, DB4
Kinoshita, K1
Tada, E1
Matsumoto, K1
Asari, S1
Ohmoto, T1
Itoh, T1
Burtscher, IM1
Ståhlberg, F1
Holtås, S1
Preul, MC2
Leblanc, R2
Caramanos, Z2
Kasrai, R1
Narayanan, S1
Arnold, DL2
Lazareff, JA1
Bockhorst, KH1
Curran, J1
Olmstead, C1
Shino, A1
Nakasu, S1
Matsuda, M1
Handa, J1
Morikawa, S1
Inubushi, T1
Villemure, JG1
Shenouda, G1
Langleben, A1
Graves, EE2
Chin, C1
Verhey, L2
Lamborn, K1
Fischbein, NJ1
Grant, PE1
Noworolski, SM1
Star-Lack, JM1
Ricci, PE1
Pitt, A1
Keller, PJ1
Coons, SW1
Heiserman, JE1
Butzen, J1
Prost, R1
Chetty, V1
Donahue, K1
Neppl, R1
Bowen, W1
Li, SJ1
Haughton, V1
Mark, L1
Kim, T1
Mueller, W1
Meyer, G1
Krouwer, H1
Rand, S1
Hall, WA1
Martin, AJ1
Truwit, CL1
Träber, F1
Block, W1
Flacke, S1
Lamerichs, R1
Schüller, H1
Urbach, H1
Keller, E1
Schild, HH1
Tzika, AA1
Zarifi, MK1
Goumnerova, L1
Astrakas, LG1
Zurakowski, D1
Young-Poussaint, T1
Anthony, DC1
Scott, RM1
Black, PM1
Unger, C2
Damenz, W1
Fleer, EA1
Kim, DJ1
Breiser, A2
Hilgard, P2
Engel, J2
Nagel, G1
Eibl, H2
von Heyden, HW1
Sindermann, H1
Peukert, M1
Nagel, GA1
Jung, EG1
Werner, D1

Clinical Trials (9)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Multi-paramEtric Imaging to Assess Treatment REsponse After Stereotactic Radiosurgery of Brain Metastases[NCT04626206]12 participants (Anticipated)Observational2020-12-31Not yet recruiting
Phase III Multicentre Prospective Comparative Study of Detection Rate of 18F-JK-PSMA-7 and of 18F-fluorocholine in Patients With Biochemical Recurrence of Prostate Cancer After Previous Treatment With Curative Intent[NCT05622162]Phase 3106 participants (Anticipated)Interventional2022-11-30Not yet recruiting
A Phase II Study to Evaluate Axumin PET/CT for Risk Stratification for Laser Focal Therapy of Intermediate Risk Localized Prostate Cancer[NCT03373006]Phase 220 participants (Actual)Interventional2018-02-27Completed
A Multi-center, Open-label, Single Arm Phase III Clinical Trial for the Diagnostic Efficacy Assessment and Safety Evaluation by [18F]Florastamin PET/CT Imaging Examination in Patients With Suspected Recurrent or Metastatic Prostate Cancer[NCT05936658]Phase 389 participants (Anticipated)Interventional2023-05-08Recruiting
Molecular Imaging of Prostate Cancer Using Radiofluorinated PSMA Ligand[NCT04266392]Early Phase 120 participants (Actual)Interventional2019-12-16Completed
WHOLE-BODY DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING (WB-DW-MRI) VS CHOLINE-POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY (CHOLINE- PET/CT) for Selecting Treatments in Recurrent Prostate Cancer[NCT02858128]46 participants (Actual)Observational2014-10-31Completed
F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer Treated by Abiraterone Acetate or Enzalutamide[NCT01981707]Phase 2/Phase 312 participants (Actual)Interventional2013-12-31Terminated (stopped due to enrollment default)
Pilot Comparative Study of PET/MR and PET/CT With Different Tracers (18F-FDG and 68Gallium Citrate) in the Diagnosis of Periprosthetic Joint Infection[NCT02855190]30 participants (Anticipated)Interventional2016-01-31Recruiting
Ependymomics: Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents[NCT05151718]370 participants (Anticipated)Observational2021-09-30Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

30 reviews available for choline and Local Neoplasm Recurrence

ArticleYear
Comparing the diagnostic performance of radiotracers in prostate cancer biochemical recurrence: a systematic review and meta-analysis.
    European radiology, 2022, Volume: 32, Issue:11

    Topics: Choline; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomograp

2022
Brain magnetic resonance spectroscopy to differentiate recurrent neoplasm from radiation necrosis: A systematic review and meta-analysis.
    Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2023, Volume: 33, Issue:2

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain; Brain Neoplasms; Child; Child, Preschool; Choline; Cr

2023
Multimodality Imaging of Prostate Cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2019, Volume: 60, Issue:10

    Topics: Aged; Antigens, Surface; Carboxylic Acids; Choline; Cyclobutanes; Disease Progression; Fluorodeoxygl

2019
Positron emission tomography (PET) radiotracers for prostate cancer imaging.
    Abdominal radiology (New York), 2020, Volume: 45, Issue:7

    Topics: Choline; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography;

2020
Prostate imaging: Contribution of PET PSMA and MRI.
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2020, Volume: 24, Issue:5

    Topics: Adenocarcinoma; Aged; Antigens, Surface; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Glut

2020
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
Is choline-based PET imaging still relevant in recurrent prostate cancer?
    BJU international, 2017, Volume: 120, Issue:3

    Topics: Aged; Aged, 80 and over; Choline; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Em

2017
The use of PET/CT in prostate cancer.
    Prostate cancer and prostatic diseases, 2018, Volume: 21, Issue:1

    Topics: Carboxylic Acids; Choline; Cyclobutanes; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Loca

2018
Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row : Nodal oligorecurrent prostate cancer.
    World journal of urology, 2019, Volume: 37, Issue:12

    Topics: Choline; Fluorine Radioisotopes; Gallium Isotopes; Gallium Radioisotopes; Humans; Lymphatic Metastas

2019
The utility of PET-based imaging for prostate cancer biochemical recurrence: a systematic review and meta-analysis.
    World journal of urology, 2019, Volume: 37, Issue:7

    Topics: Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Gallium Isotopes; Gallium Radioisotop

2019
Accuracy of 11C-choline positron emission tomography in differentiating glioma recurrence from radiation necrosis: A systematic review and meta-analysis.
    Medicine, 2018, Volume: 97, Issue:29

    Topics: Carbon Radioisotopes; Choline; Diagnosis, Differential; Glioma; Humans; Necrosis; Neoplasm Recurrenc

2018
Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40 Suppl 1

    Topics: Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positro

2013
The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques?
    Current radiopharmaceuticals, 2013, Jun-06, Volume: 6, Issue:2

    Topics: Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Fluorine Radioisotope

2013
The role of positron emission tomography/computed tomography imaging with radiolabeled choline analogues in prostate cancer.
    Actas urologicas espanolas, 2014, Volume: 38, Issue:9

    Topics: Choline; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Co

2014
Choline-PET in prostate cancer management: the point of view of the radiation oncologist.
    Critical reviews in oncology/hematology, 2014, Volume: 91, Issue:3

    Topics: Biomarkers, Tumor; Bone Neoplasms; Choline; Gamma Rays; Humans; Male; Neoplasm Recurrence, Local; Po

2014
[Multimodality MRI and PET for restaging prostate cancer after biochemical failure of the treatment].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2014, Volume: 18, Issue:5-6

    Topics: Adenocarcinoma; Brachytherapy; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglu

2014
[Imagery of treated prostate cancer].
    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2015, Volume: 25, Issue:3

    Topics: Choline; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neopl

2015
Differentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-Analysis.
    PloS one, 2016, Volume: 11, Issue:1

    Topics: Aspartic Acid; Blood Volume; Brain; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Hum

2016
Rapidly changing landscape of PET/CT imaging in prostate cancer.
    Current opinion in urology, 2016, Volume: 26, Issue:5

    Topics: Antigens, Surface; Choline; Glutamate Carboxypeptidase II; Humans; Male; Neoplasm Recurrence, Local;

2016
Radiolabeled choline PET/CT before salvage lymphadenectomy dissection: a systematic review and meta-analysis.
    Nuclear medicine communications, 2016, Volume: 37, Issue:12

    Topics: Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Positr

2016
11C- or 18F-Choline PET/CT for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:Suppl 3

    Topics: Choline; Diagnosis, Differential; Evidence-Based Medicine; Humans; Image Enhancement; Male; Neoplasm

2016
The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer.
    European urology, 2011, Volume: 59, Issue:1

    Topics: Carbon Radioisotopes; Choline; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-

2011
[Diagnostic relevance of choline-PET / CT in patients with prostate cancer].
    Aktuelle Urologie, 2012, Volume: 43, Issue:1

    Topics: Bone Neoplasms; Carbon Radioisotopes; Choline; Disease Progression; Fluorine Radioisotopes; Humans;

2012
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.
    Prostate cancer and prostatic diseases, 2012, Volume: 15, Issue:1

    Topics: Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplas

2012
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.
    Prostate cancer and prostatic diseases, 2012, Volume: 15, Issue:1

    Topics: Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplas

2012
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.
    Prostate cancer and prostatic diseases, 2012, Volume: 15, Issue:1

    Topics: Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplas

2012
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.
    Prostate cancer and prostatic diseases, 2012, Volume: 15, Issue:1

    Topics: Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplas

2012
[Choline PET/CT in the diagnosis of primary and recurrent prostate cancer. Are there evidence-based indications?].
    Der Urologe. Ausg. A, 2012, Volume: 51, Issue:6

    Topics: Choline; Clinical Trials as Topic; Evidence-Based Medicine; Humans; Male; Multimodal Imaging; Neopla

2012
[1H magnetic resonance spectroscopy of the prostate].
    Der Radiologe, 2003, Volume: 43, Issue:6

    Topics: Biopsy; Choline; Citrates; Creatine; Follow-Up Studies; Humans; Imaging, Three-Dimensional; Magnetic

2003
[Clinical usefulness of positron emission tomography in prostate cancer].
    Presse medicale (Paris, France : 1983), 2007, Volume: 36, Issue:12 Pt 2

    Topics: Bone Neoplasms; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recu

2007
Proton MR spectroscopy of the prostate.
    European journal of radiology, 2007, Volume: 63, Issue:3

    Topics: Biopsy; Choline; Citric Acid; Creatine; Diagnosis, Differential; Humans; Imaging, Three-Dimensional;

2007
[Nuclear imaging of prostate cancer: current status].
    Der Urologe. Ausg. A, 2007, Volume: 46, Issue:11

    Topics: Carbon Radioisotopes; Choline; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Magnetic Re

2007
Is there a role for positron emission tomography imaging in the early evaluation of prostate cancer relapse?
    Prostate cancer and prostatic diseases, 2008, Volume: 11, Issue:2

    Topics: Adenocarcinoma; Carbon Radioisotopes; Choline; Clinical Trials as Topic; Humans; Lymphatic Metastasi

2008

Trials

17 trials available for choline and Local Neoplasm Recurrence

ArticleYear
Pseudoprogression in GBM versus true progression in patients with glioblastoma: A multiapproach analysis.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2023, Volume: 181

    Topics: Brain Neoplasms; Choline; Disease Progression; Glioblastoma; Humans; Magnetic Resonance Imaging; Neo

2023
Comparison of 18F-PSMA-1007 and 18F-Choline PET/CT in prostate cancer patients with biochemical recurrence: a phase 3, prospective, multicenter, randomized study.
    Nuclear medicine communications, 2023, Dec-01, Volume: 44, Issue:12

    Topics: Choline; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomograp

2023
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677.
    Neuro-oncology, 2013, Volume: 15, Issue:7

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Be

2013
Diagnostic accuracy of 18F choline PET/CT using time-of-flight reconstruction algorithm in prostate cancer patients with biochemical recurrence.
    Clinical nuclear medicine, 2014, Volume: 39, Issue:3

    Topics: Algorithms; Choline; Humans; Image Processing, Computer-Assisted; Male; Multimodal Imaging; Neoplasm

2014
First imaging results of an intraindividual comparison of (11)C-acetate and (18)F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second relapse after prostatectomy or radiotherapy.
    European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:1

    Topics: Acetates; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Ma

2014
Value of fused 18F-Choline-PET/MRI to evaluate prostate cancer relapse in patients showing biochemical recurrence after EBRT: preliminary results.
    BioMed research international, 2014, Volume: 2014

    Topics: Aged; Aged, 80 and over; Choline; Humans; Male; Neoplasm Recurrence, Local; Positron-Emission Tomogr

2014
Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.
    International journal of radiation oncology, biology, physics, 2014, Oct-01, Volume: 90, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Aspartic Acid; Biomarkers, Tumor; Brain Neoplasms; Choline; Crea

2014
BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study).
    Molecular imaging and biology, 2015, Volume: 17, Issue:3

    Topics: Aged; Aged, 80 and over; Bone Marrow; Choline; Fluorodeoxyglucose F18; Glutarates; Humans; Lymphatic

2015
Whole-body diffusion-weighted magnetic resonance imaging (WB-DW-MRI) vs choline-positron emission tomography-computed tomography (choline-PET/CT) for selecting treatments in recurrent prostate cancer.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2017, Volume: 19, Issue:5

    Topics: Aged; Aged, 80 and over; Choline; Diffusion Magnetic Resonance Imaging; Humans; Male; Middle Aged; N

2017
Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP).
    European journal of radiology, 2012, Volume: 81, Issue:4

    Topics: Aged; Choline; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Age

2012
A pilot comparison of 18F-fluorodeoxyglucose and 18F-fluorocholine PET/CT to predict early recurrence of unifocal hepatocellular carcinoma after surgical resection.
    Nuclear medicine communications, 2012, Volume: 33, Issue:7

    Topics: Aged; Carcinoma, Hepatocellular; Choline; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hum

2012
11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer.
    European urology, 2003, Volume: 44, Issue:1

    Topics: Aftercare; Aged; Aged, 80 and over; Biopsy, Needle; Brachytherapy; Choline; Cohort Studies; Humans;

2003
11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer.
    European urology, 2003, Volume: 44, Issue:1

    Topics: Aftercare; Aged; Aged, 80 and over; Biopsy, Needle; Brachytherapy; Choline; Cohort Studies; Humans;

2003
11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer.
    European urology, 2003, Volume: 44, Issue:1

    Topics: Aftercare; Aged; Aged, 80 and over; Biopsy, Needle; Brachytherapy; Choline; Cohort Studies; Humans;

2003
11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer.
    European urology, 2003, Volume: 44, Issue:1

    Topics: Aftercare; Aged; Aged, 80 and over; Biopsy, Needle; Brachytherapy; Choline; Cohort Studies; Humans;

2003
Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:7

    Topics: Adenocarcinoma; Adult; Aged; Carbon Radioisotopes; Carcinoma, Squamous Cell; Carcinosarcoma; Choline

2003
Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Choline; Humans; Image Enhancement; Image Interpretation, Computer-A

2006
Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
    Journal of neuro-oncology, 2007, Volume: 84, Issue:1

    Topics: Adult; Aged; Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Fema

2007
Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study.
    International journal of radiation oncology, biology, physics, 2008, Mar-01, Volume: 70, Issue:3

    Topics: Adult; Aspartic Acid; Brain Neoplasms; Choline; Female; Glioblastoma; Humans; Magnetic Resonance Ima

2008

Other Studies

190 other studies available for choline and Local Neoplasm Recurrence

ArticleYear
Detection rate of 18F-Choline positron emission tomography/computed tomography in patients with non-metastatic hormone sensitive and castrate resistant prostate cancer.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2023, Volume: 67, Issue:2

    Topics: Choline; Hormones; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed T

2023
COVID-19 Vaccination Manifesting as Unilateral Lymphadenopathies Detected by 18F-Choline PET/CT.
    Clinical nuclear medicine, 2022, Feb-01, Volume: 47, Issue:2

    Topics: Aged; Choline; COVID-19; COVID-19 Vaccines; Humans; Lymphadenopathy; Male; Neoplasm Recurrence, Loca

2022
Can pre-transplant 18F-choline positron emission tomography predict relapse following autologous stem cell transplantation in primary central nervous system lymphoma?
    Bone marrow transplantation, 2022, Volume: 57, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neopl

2022
Distinguishing Tumor Recurrence From Radiation Necrosis in Treated Glioblastoma Using Multiparametric MRI.
    Academic radiology, 2022, Volume: 29, Issue:9

    Topics: Brain Neoplasms; Choline; Creatine; Diffusion Magnetic Resonance Imaging; Diffusion Tensor Imaging;

2022
Prognostic Potential of Postoperative 18F-Fluorocholine PET/CT in Patients With High-Grade Glioma. Clinical Validation of FuMeGA Postoperative PET Criteria.
    Clinical nuclear medicine, 2022, Jun-01, Volume: 47, Issue:6

    Topics: Choline; Glioma; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomograph

2022
Diagnostic Performance of Preoperative Choline-PET/CT in Patients Undergoing Salvage Lymph Node Dissection for Recurrent Prostate Cancer: A Multicenter Experience.
    Tomography (Ann Arbor, Mich.), 2022, 04-11, Volume: 8, Issue:2

    Topics: Choline; Humans; Lymph Node Excision; Male; Neoplasm Recurrence, Local; Positron Emission Tomography

2022
[Intermediate-risk prostate cancer treated with exclusive external irradiation: Focus on anatomical sites of recurrence in two French trials].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2022, Volume: 26, Issue:5

    Topics: Choline; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography;

2022
Early Recurrence Detection of Glioma Using 18 F-Fluorocholine PET/CT : GliReDe Pilot Study.
    Clinical nuclear medicine, 2022, Oct-01, Volume: 47, Issue:10

    Topics: Choline; Early Diagnosis; Glioma; Humans; Neoplasm Recurrence, Local; Pilot Projects; Positron Emiss

2022
Metastasis-directed Therapy Without Androgen Deprivation Therapy in Solitary Oligorecurrent Prostate Cancer.
    The Journal of urology, 2022, Volume: 208, Issue:6

    Topics: Androgen Antagonists; Androgens; Choline; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, L

2022
Superscan-Like Pattern on 18F-Choline PET/CT in a Patient With Essential Thrombocythemia.
    Clinical nuclear medicine, 2023, Mar-01, Volume: 48, Issue:3

    Topics: Choline; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography;

2023
Is 18 F-FDG/ 18 F-Choline Dual-Tracer PET Behavior a Surrogate of Tumor Differentiation in Hepatocellular Carcinoma : A Tertiary Center Dedicated Study.
    Clinical nuclear medicine, 2023, Apr-01, Volume: 48, Issue:4

    Topics: Carcinoma, Hepatocellular; Choline; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurr

2023
Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trial.
    Cancer imaging : the official publication of the International Cancer Imaging Society, 2023, Jun-08, Volume: 23, Issue:1

    Topics: Androgen Antagonists; Choline; Humans; Male; Neoplasm Recurrence, Local; Patient Selection; Positron

2023
18F-Fluorocholine PET/CT in the Detection of Hyperfunctioning Transplanted Parathyroid Tissue.
    Clinical nuclear medicine, 2023, Dec-01, Volume: 48, Issue:12

    Topics: Choline; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Middle Aged; Neoplasm Recurren

2023
Chordoid glioma: an entity occurring not exclusively in the third ventricle.
    Neurosurgical review, 2020, Volume: 43, Issue:5

    Topics: Adult; Aged; Aspartic Acid; Cerebellum; Cerebral Ventricle Neoplasms; Choline; Diffusion Magnetic Re

2020
Evaluation of Treatment Response in Prostate Cancer and Renal Cell Carcinoma Patients Using 11C-choline PET/CT Findings.
    Acta medica Okayama, 2019, Volume: 73, Issue:4

    Topics: Aged; Carbon Radioisotopes; Carcinoma, Renal Cell; Choline; Female; Humans; Male; Middle Aged; Neopl

2019
    European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:6

    Topics: Brain Neoplasms; Choline; Humans; Kinetics; Neoplasm Recurrence, Local; Positron Emission Tomography

2020
Editorial commentary to "
    European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:6

    Topics: Brain Neoplasms; Choline; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiosur

2020
18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up.
    La Radiologia medica, 2020, Volume: 125, Issue:7

    Topics: Aged; Aged, 80 and over; Choline; Disease Progression; Follow-Up Studies; Humans; Male; Middle Aged;

2020
Editorial Comment.
    The Journal of urology, 2020, Volume: 204, Issue:2

    Topics: Carbon Radioisotopes; Choline; Gallium Isotopes; Gallium Radioisotopes; Humans; Lymph Node Excision;

2020
Editorial Comment.
    The Journal of urology, 2020, Volume: 204, Issue:2

    Topics: Carbon Radioisotopes; Choline; Gallium Isotopes; Gallium Radioisotopes; Humans; Lymph Node Excision;

2020
COVID-19 pneumonia: increased choline uptake with 18F-choline PET/CT.
    European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:10

    Topics: Choline; Coronavirus Infections; COVID-19; Disease Progression; Humans; Inflammation; Lung; Macropha

2020
Diagnostic performance of imaging techniques for detecting of local recurrence after prostate brachytherapy.
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2020, Volume: 24, Issue:4

    Topics: Aged; Biopsy; Brachytherapy; Choline; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplas

2020
Radiomics analysis of 18F-Choline PET/CT in the prediction of disease outcome in high-risk prostate cancer: an explorative study on machine learning feature classification in 94 patients.
    European radiology, 2021, Volume: 31, Issue:7

    Topics: Artificial Intelligence; Choline; Humans; Machine Learning; Male; Neoplasm Recurrence, Local; Positr

2021
Prognostic Risk Classification for Biochemical Relapse-Free Survival in Oligometastatic Recurrent Prostate Cancer Determined by Choline PET.
    Clinical genitourinary cancer, 2021, Volume: 19, Issue:4

    Topics: Androgen Antagonists; Choline; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomograph

2021
Bone Marrow Activation After Chemotherapy Presenting as Diffuse Skeletal Uptake on 18F-Fluorocholine PET/CT.
    Clinical nuclear medicine, 2021, Oct-01, Volume: 46, Issue:10

    Topics: Bone Marrow; Choline; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Positron Emi

2021
Skeletal Muscle Metastases in HCC Revealed by 18F-Choline PET/CT.
    Clinical nuclear medicine, 2021, Dec-01, Volume: 46, Issue:12

    Topics: Aged; Carcinoma, Hepatocellular; Choline; Humans; Liver Neoplasms; Male; Muscle, Skeletal; Neoplasm

2021
Comparison of MRI, PET, and 18F-choline PET/MRI in patients with oligometastatic recurrent prostate cancer.
    Abdominal radiology (New York), 2021, Volume: 46, Issue:9

    Topics: Choline; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Positron Emission Tom

2021
Comparison between MRI and choline-PET trans-perineal target biopsies and saturation biopsies for detection and topography of intra-prostatic recurrence after primary radiation therapy for prostate cancer.
    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2021, Volume: 31, Issue:12

    Topics: Biopsy; Choline; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Positron Emis

2021
    International journal of radiation oncology, biology, physics, 2017, 04-01, Volume: 97, Issue:5

    Topics: Aged; Biopsy; Choline; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle

2017
Role of PET-CT with
    Actas urologicas espanolas, 2017, Volume: 41, Issue:7

    Topics: Aged; Aged, 80 and over; Choline; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Em

2017
Identification of Recurrence Sites Following Post-Prostatectomy Treatment for Prostate Cancer Using
    The Journal of urology, 2018, Volume: 199, Issue:3

    Topics: Aged; Choline; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal

2018
11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients.
    Current radiopharmaceuticals, 2017, Nov-10, Volume: 10, Issue:3

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis

2017
Target definition in salvage postoperative radiotherapy for prostate cancer: 18F-fluorocholine PET/CT assessment of local recurrence.
    Acta oncologica (Stockholm, Sweden), 2018, Volume: 57, Issue:3

    Topics: Aged; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positr

2018
Management of biochemically recurrent prostate cancer: molecular imaging perspective.
    World journal of urology, 2018, Volume: 36, Issue:2

    Topics: Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Humans; Male; Molecular Imaging; Neop

2018
Editorial Comment.
    The Journal of urology, 2018, Volume: 199, Issue:3

    Topics: Carbon Radioisotopes; Choline; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local;

2018
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis.
    European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:5

    Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Humans; Liver Neoplasms; Male; Middle Aged;

2018
18F-fluorocholine PET/CT in patients with occult biochemical recurrence of prostate cancer: Detection rate, impact on management and adequacy of impact. A prospective multicentre study.
    PloS one, 2018, Volume: 13, Issue:2

    Topics: Aged; Aged, 80 and over; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Multimodal Imag

2018
18F-Choline PET/MR Can Detect and Delineate Local Recurrence After High-Intensity Focused Ultrasound Therapy of Prostate Cancer.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:4

    Topics: Choline; Extracorporeal Shockwave Therapy; Humans; Magnetic Resonance Imaging; Male; Multimodal Imag

2018
The relationship between local recurrences and distant metastases in prostate cancer: can
    European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:6

    Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Neoplasm Metastas

2018
Diagnostic performance of a streamlined
    Clinical radiology, 2018, Volume: 73, Issue:7

    Topics: Aged; Aged, 80 and over; Choline; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Em

2018
Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT in Prostate Cancer.
    Acta medica Okayama, 2018, Volume: 72, Issue:3

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Huma

2018
Robotic salvage lymph node dissection for nodal-only recurrences after radical prostatectomy: Perioperative and early oncological outcomes.
    Surgical oncology, 2018, Volume: 27, Issue:2

    Topics: Aged; Aged, 80 and over; Choline; Follow-Up Studies; Humans; Lymph Node Excision; Lymph Nodes; Male;

2018
Diagnostic performance of
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2019, Volume: 21, Issue:6

    Topics: Aged; Choline; Fluorine Radioisotopes; Follow-Up Studies; Humans; Male; Neoplasm Grading; Neoplasm R

2019
68Ga-PSMA-11 PET-CT study in prostate cancer patients with biochemical recurrence and non-contributive 18F-Choline PET-CT: Impact on therapeutic decision-making and biomarker changes.
    The Prostate, 2019, Volume: 79, Issue:5

    Topics: Aged; Aged, 80 and over; Choline; Decision Making; Edetic Acid; Gallium Isotopes; Gallium Radioisoto

2019
Usefulness of 18F-fluorocoline PET/CT in prostate cancer patients with biochemical recurrence: Influence of PSA kinetics and hormone therapy.
    Medicina clinica, 2019, 07-19, Volume: 153, Issue:2

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Choline; Humans; Male; Middle Aged; Neoplasm Recurren

2019
Reirradiation of Locally Recurrent Prostate Cancer With Volumetric Modulated Arc Therapy.
    International journal of radiation oncology, biology, physics, 2019, 07-01, Volume: 104, Issue:3

    Topics: Aged; Aged, 80 and over; Choline; Dose Fractionation, Radiation; Feasibility Studies; Humans; Male;

2019
18F-Prostate-Specific Membrane Antigen 1007 and 18F-FCH PET/CT in Local Recurrence of Prostate Cancer.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:6

    Topics: Aged; Choline; Fluorine Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Niacinamide; Oligop

2019
Outcomes after a first and/or second salvage treatment in patients with oligometastatic prostate cancer recurrence detected by (18-F) choline PET-CT.
    European journal of cancer care, 2019, Volume: 28, Issue:5

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Bone Neoplasms; Carcinoma; Choline; Fluori

2019
Recurrent prostate cancer after radical prostatectomy: restaging performance of 18F-choline hybrid PET/MRI.
    Medical oncology (Northwood, London, England), 2019, Jun-12, Volume: 36, Issue:8

    Topics: Aged; Aged, 80 and over; Choline; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male;

2019
Recurrent prostatic adenocarcinoma with perineural spread to the lumbosacral plexus and sciatic nerve: comparing high resolution MRI with torso and endorectal coils and F-18 FDG and C-11 choline PET/CT.
    Abdominal imaging, 2013, Volume: 38, Issue:5

    Topics: Adenocarcinoma; Aged, 80 and over; Biopsy; Choline; Fluorodeoxyglucose F18; Humans; Lumbosacral Plex

2013
Influence of androgen deprivation therapy on choline PET/CT in recurrent prostate cancer.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40 Suppl 1

    Topics: Androgen Antagonists; Androgens; Choline; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Loc

2013
Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40 Suppl 1

    Topics: Aged; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Humans; Limit of Detection; Mal

2013
Utility of [11C]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: results from a pathologically validated series.
    Urologic oncology, 2014, Volume: 32, Issue:1

    Topics: Aged; Androgen Antagonists; Carbon Radioisotopes; Choline; Humans; Lymph Node Excision; Lymph Nodes;

2014
The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level <0.5 ng/mL.
    Clinical nuclear medicine, 2013, Volume: 38, Issue:9

    Topics: Carbon Radioisotopes; Choline; Early Detection of Cancer; Humans; Logistic Models; Male; Middle Aged

2013
Incidental detection of Leydig cell tumor via fluorine-18-Choline PET/CT in a patient with recurrent prostate cancer disease.
    Clinical nuclear medicine, 2013, Volume: 38, Issue:9

    Topics: Choline; Fluorine Radioisotopes; Humans; Incidental Findings; Leydig Cell Tumor; Male; Neoplasm Recu

2013
11C choline PET guided salvage radiotherapy with volumetric modulation arc therapy and hypofractionation for recurrent prostate cancer after HIFU failure: preliminary results of tolerability and acute toxicity.
    Technology in cancer research & treatment, 2014, Volume: 13, Issue:5

    Topics: Aged; Aged, 80 and over; Choline; Diarrhea; Dose Fractionation, Radiation; Humans; Male; Middle Aged

2014
18F-FACBC compared with 11C-choline PET/CT in patients with biochemical relapse after radical prostatectomy: a prospective study in 28 patients.
    Clinical genitourinary cancer, 2014, Volume: 12, Issue:2

    Topics: Aged; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Humans; Male; Middle Aged; Neop

2014
Radiation dosimetry of 18F-fluorocholine PET/CT studies in prostate cancer patients.
    Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB), 2014, Volume: 30, Issue:3

    Topics: Aged; Aged, 80 and over; Choline; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Organs at R

2014
Prostate-specific antigen kinetics parameters are predictive of positron emission tomography features worsening in patients with biochemical relapse after prostate cancer treatment with radical intent: Results from a longitudinal cohort study.
    Scandinavian journal of urology, 2014, Volume: 48, Issue:3

    Topics: Aged; Choline; Cohort Studies; Disease Progression; Humans; Kallikreins; Longitudinal Studies; Male;

2014
Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis.
    Neurologia medico-chirurgica, 2014, Volume: 54, Issue:4

    Topics: Adult; Aged; Area Under Curve; Brain; Brain Neoplasms; Carbon Isotopes; Choline; Combined Modality T

2014
First case of 18F-FACBC PET/CT-guided salvage retroperitoneal lymph node dissection for disease relapse after radical prostatectomy for prostate cancer and negative 11C-choline PET/CT: new imaging techniques may expand pioneering approaches.
    Urologia internationalis, 2014, Volume: 92, Issue:2

    Topics: Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Humans; Lymph Node Excision; Lymphati

2014
11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:2

    Topics: Androgen Antagonists; Carbon Radioisotopes; Choline; Disease-Free Survival; Humans; Image Processing

2014
Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:2

    Topics: Aged; Aged, 80 and over; Area Under Curve; Carbon Radioisotopes; Choline; Humans; Image Processing,

2014
The optimal timing to perform 18F/11C-choline PET/CT in patients with suspicion of relapse of prostate cancer: trigger PSA versus PSA velocity and PSA doubling time.
    The International journal of biological markers, 2014, Dec-09, Volume: 29, Issue:4

    Topics: Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Pos

2014
Detection of lymph node metastasis in patients with nodal prostate cancer relapse using (18)F/(11)C-choline positron emission tomography/computerized tomography.
    The Journal of urology, 2014, Volume: 192, Issue:1

    Topics: Aged; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplas

2014
Pattern of occult nodal relapse diagnosed with (18)F-fluoro-choline PET/CT in prostate cancer patients with biochemical failure after prostate-only radiotherapy.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2014, Volume: 111, Issue:1

    Topics: Choline; Fluorine Radioisotopes; Humans; Kallikreins; Lymph Nodes; Lymphatic Metastasis; Male; Multi

2014
Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-Choline PET/CT scan before salvage radiation therapy?
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:9

    Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Multimodal Imagin

2014
3-Dimensional magnetic resonance spectroscopic imaging at 3 Tesla for early response assessment of glioblastoma patients during external beam radiation therapy.
    International journal of radiation oncology, biology, physics, 2014, Sep-01, Volume: 90, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Aspartic Acid; Biomarkers, Tumor; Brain Neoplasms; C

2014
¹⁸F-choline positron emission tomography/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: feasibility study in 60 patients.
    International journal of radiation oncology, biology, physics, 2014, Oct-01, Volume: 90, Issue:2

    Topics: Aged; Aged, 80 and over; Choline; Disease Progression; Feasibility Studies; Fluorine Radioisotopes;

2014
Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer.
    Radiation oncology (London, England), 2014, Aug-12, Volume: 9

    Topics: Aged; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Lymph Node Excision; Lymphatic

2014
Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography.
    The Journal of urology, 2015, Volume: 193, Issue:1

    Topics: Aged; Carbon Radioisotopes; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle

2015
(11)C-choline PET/CT tumor recurrence detection and survival prediction in post-treatment patients with high-grade gliomas.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2014, Volume: 35, Issue:12

    Topics: Adult; Aged; Brain; Brain Neoplasms; Choline; Female; Follow-Up Studies; Glioma; Humans; Magnetic Re

2014
Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
    American journal of clinical oncology, 2017, Volume: 40, Issue:3

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Brachytherapy; Carbon Radioisotopes; Choline; Humans; Lymph

2017
Role of 11C-choline positron emission tomography in prostate cancer recurrence--potential for delayed cure or just resetting the clock of the disease?
    The Journal of urology, 2015, Volume: 193, Issue:1

    Topics: Carbon Radioisotopes; Choline; Humans; Lymph Node Excision; Male; Multimodal Imaging; Neoplasm Recur

2015
Prostate cancer: Identifying sites of recurrence with choline-PET-CT imaging.
    Nature reviews. Urology, 2015, Volume: 12, Issue:3

    Topics: Carbon Radioisotopes; Choline; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positro

2015
(11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer.
    Actas urologicas espanolas, 2015, Volume: 39, Issue:4

    Topics: Adenocarcinoma; Bone Neoplasms; Carbon Radioisotopes; Choline; Combined Modality Therapy; Humans; Ly

2015
Molecular imaging of prostate cancer: tapping into the opportunities.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:2

    Topics: Choline; Humans; Male; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; P

2015
Gleason score at diagnosis predicts the rate of detection of 18F-choline PET/CT performed when biochemical evidence indicates recurrence of prostate cancer: experience with 1,000 patients.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:2

    Topics: Aged; Analysis of Variance; Biopsy; Choline; Humans; Male; Middle Aged; Multivariate Analysis; Neopl

2015
Significant increase in detection of prostate cancer recurrence following radical prostatectomy with an early imaging acquisition protocol with ¹⁸F-fluorocholine positron emission tomography/computed tomography.
    World journal of urology, 2015, Volume: 33, Issue:10

    Topics: Aged; Choline; Early Detection of Cancer; Fluorine Radioisotopes; Follow-Up Studies; Humans; Male; M

2015
Value of bimodal (18)F-choline-PET/MRI and trimodal (18)F-choline-PET/MRI/TRUS for the assessment of prostate cancer recurrence after radiation therapy and radical prostatectomy.
    Abdominal imaging, 2015, Volume: 40, Issue:6

    Topics: Aged; Aged, 80 and over; Choline; Diagnosis, Computer-Assisted; Fluorine Radioisotopes; Humans; Imag

2015
In reply to Zilli and Miralbell.
    International journal of radiation oncology, biology, physics, 2015, Mar-01, Volume: 91, Issue:3

    Topics: Choline; Fluorine Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms; Radi

2015
High-dose salvage radiation therapy for prostate cancer after relapse: in regard to D'Angelillo et al.
    International journal of radiation oncology, biology, physics, 2015, Mar-01, Volume: 91, Issue:3

    Topics: Choline; Fluorine Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms; Radi

2015
[Biochemical recurrence after curative treatment for localized prostate cancer: Performance of choline PET/CT in the assessment of local recurrence].
    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2015, Volume: 25, Issue:6

    Topics: Adenocarcinoma; Aged; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Multimodal Imaging

2015
Quantification of serial changes in cerebral blood volume and metabolism in patients with recurrent glioblastoma undergoing antiangiogenic therapy.
    European journal of radiology, 2015, Volume: 84, Issue:6

    Topics: Angiogenesis Inhibitors; Aspartic Acid; Bevacizumab; Blood Volume; Brain; Brain Mapping; Brain Neopl

2015
(18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy.
    World journal of urology, 2015, Volume: 33, Issue:11

    Topics: Aged; Choline; Combined Modality Therapy; Diagnosis, Differential; Early Diagnosis; Fluorine Radiois

2015
Targeted salvage lymphadenectomy in patients treated with radical prostatectomy with biochemical recurrence: complete biochemical response without adjuvant therapy in patients with low volume lymph node recurrence over a long-term follow-up.
    BMC urology, 2015, Feb-21, Volume: 15

    Topics: Aged; Biopsy, Needle; Choline; Cohort Studies; Follow-Up Studies; Humans; Immunohistochemistry; Lymp

2015
18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse: A Comparison to 11C-Choline PET/CT.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:8

    Topics: Aged; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Humans; Male; Middle Aged; Mult

2015
18F-Choline PET/CT and Prostate MRI for Staging Patients With Biochemical Relapse After Irradiation for Prostate Cancer.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:11

    Topics: Aged; Case-Control Studies; Choline; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimod

2015
Detection of local recurrence of prostate cancer after radical prostatectomy: Is there a role for early ¹⁸F-FCH PET/CT?
    Annals of nuclear medicine, 2015, Volume: 29, Issue:10

    Topics: Aged; Choline; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomog

2015
Prognostic Value of MRS Metabolites in Postoperative Irradiated High Grade Gliomas.
    BioMed research international, 2015, Volume: 2015

    Topics: Adult; Age Factors; Aged; Choline; Creatine; Disease-Free Survival; Female; Glioma; Humans; Magnetic

2015
Radiation Treatment of Lymph Node Recurrence from Prostate Cancer: Is 11C-Choline PET/CT Predictive of Survival Outcomes?
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:12

    Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Disease-Free Survival; Female; Humans; Image

2015
The ability of 18F-choline PET/CT to identify local recurrence of prostate cancer.
    Abdominal imaging, 2015, Volume: 40, Issue:8

    Topics: Aged; Aged, 80 and over; Choline; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence

2015
Intensity-modulated salvage radiotherapy with simultaneous integrated boost for local recurrence of prostate carcinoma: a pilot study on the place of PET-choline for guiding target volume delineation.
    The British journal of radiology, 2016, Volume: 89, Issue:1058

    Topics: Aged; Choline; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Pilot Projects; Positro

2016
PET/CT and MRI directed extended salvage radiotherapy in recurrent prostate cancer with lymph node metastases.
    Advances in medical sciences, 2016, Volume: 61, Issue:2

    Topics: Aged; Choline; Cohort Studies; Contrast Media; Disease Progression; Follow-Up Studies; Humans; Lymph

2016
Recurrent Extrahepatic Hepatocellular Carcinoma Detected by 18F-Choline PET/CT.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:6

    Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Choline; Female; Fluorine Radioisotopes; Humans; Live

2016
Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment.
    Radiation oncology (London, England), 2016, Mar-11, Volume: 11

    Topics: Aged; Aged, 80 and over; Choline; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neop

2016
68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:7

    Topics: Aged; Aged, 80 and over; Antigens, Surface; Choline; Gallium Radioisotopes; Glutamate Carboxypeptida

2016
[ROLE OF KINETIC PERFORMANCE OF PSA IN SELECTION OF THE PATIENTS FOR CONDUCTION OF 11C-CHOLINE PET/CT AIMED TO REVEAL LOCAL RECURRENCES OF PROSTATE CANCER].
    Vestnik khirurgii imeni I. I. Grekova, 2015, Volume: 174, Issue:6

    Topics: Aged; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm

2015
A pilot study of the utility of choline PET-CT in prostate cancer biochemical relapse following radical prostatectomy.
    Journal of medical imaging and radiation oncology, 2016, Volume: 60, Issue:3

    Topics: Choline; Humans; Longitudinal Studies; Male; Neoplasm Recurrence, Local; Pilot Projects; Positron Em

2016
Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer.
    BJU international, 2017, Volume: 119, Issue:3

    Topics: Aged; Aged, 80 and over; Choline; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imagin

2017
(11)C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:11

    Topics: Aged; Aged, 80 and over; Choline; Disease-Free Survival; Feasibility Studies; Humans; Italy; Lymphat

2016
[PET/CT with 18F-Fluorocholine in Patients with Prostatic Cancer in Biochemical Recurrence].
    Acta medica portuguesa, 2016, Volume: 29, Issue:3

    Topics: Aged; Aged, 80 and over; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Neoplasm Recurr

2016
Contemporary Mapping of Post-Prostatectomy Prostate Cancer Relapse with
    The Journal of urology, 2017, Volume: 197, Issue:1

    Topics: Academic Medical Centers; Aged; Analysis of Variance; Biopsy, Needle; Carbon Radioisotopes; Choline;

2017
[11C]Choline PET/CT in therapy response assessment of a neoadjuvant therapy in locally advanced and high risk prostate cancer before radical prostatectomy.
    Oncotarget, 2016, Sep-27, Volume: 7, Issue:39

    Topics: Aged; Antineoplastic Agents; Apoptosis; Biopsy; Carbon Isotopes; Choline; Humans; Lymph Nodes; Male;

2016
Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series.
    Cancer imaging : the official publication of the International Cancer Imaging Society, 2016, Aug-31, Volume: 16, Issue:1

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorodeoxyglucose F18; Humans; Kallikreins; Lung

2016
Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: A Nomogram for Predicting Extrapelvic Disease.
    European urology, 2017, Volume: 71, Issue:3

    Topics: Aged; Carbon Radioisotopes; Choline; Humans; Logistic Models; Male; Middle Aged; Multivariate Analys

2017
Choline Positron Emission Tomography/Computed Tomography for Selection of Patients for Salvage Strategies After Primary Local Treatment of Prostate Cancer and Rising Prostate-specific Antigen: Ready for Prime Time?
    European urology, 2017, Volume: 71, Issue:3

    Topics: Carbon Radioisotopes; Choline; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positro

2017
Reply from Authors re: Alberto Bossi, Nicolas Mottet, Pierre Blanchard. Choline Positron Emission Tomography/Computed Tomography for Selection of Patients for Salvage Strategies After Primary Local Treatment of Prostate Cancer and Rising Prostate-specific
    European urology, 2017, Volume: 71, Issue:3

    Topics: Carbon Radioisotopes; Choline; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positro

2017
Evaluation of tumor recurrences after radical prostatectomy using 18F-Choline PET/CT and 3T multiparametric MRI without endorectal coil: a single center experience.
    Cancer imaging : the official publication of the International Cancer Imaging Society, 2016, Dec-07, Volume: 16, Issue:1

    Topics: Aged; Choline; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Po

2016
Salvage Lymph Node Dissection for Node-only Recurrence of Prostate Cancer: Ready for Prime Time?
    European urology, 2017, Volume: 71, Issue:5

    Topics: Carbon Radioisotopes; Choline; Humans; Kallikreins; Lymph Node Excision; Lymph Nodes; Male; Neoplasm

2017
Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography.
    International journal of radiation oncology, biology, physics, 2017, 03-01, Volume: 97, Issue:3

    Topics: Aged; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Middle Aged

2017
[Visualization of prostate cancer with 11C-choline positron emission tomography (PET): localization of primary and recurrent prostate cancer].
    Hinyokika kiyo. Acta urologica Japonica, 2008, Volume: 54, Issue:5

    Topics: Aged; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron

2008
[11C]Choline PET/CT for targeted salvage lymph node dissection in patients with biochemical recurrence after primary curative therapy for prostate cancer. Preliminary results of a prospective study.
    Urologia internationalis, 2008, Volume: 81, Issue:2

    Topics: Aged; Biomarkers; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neo

2008
In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0 Tesla.
    BJOG : an international journal of obstetrics and gynaecology, 2009, Volume: 116, Issue:2

    Topics: Biomarkers, Tumor; Choline; Female; Genital Neoplasms, Female; Humans; Lipids; Magnetic Resonance Sp

2009
Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions.
    AJR. American journal of roentgenology, 2009, Volume: 192, Issue:2

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain Neoplasms; Child; Child, Preschool; Choline; Contrast

2009
Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence.
    Nuklearmedizin. Nuclear medicine, 2009, Volume: 48, Issue:1

    Topics: Aged; Aged, 80 and over; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Neoplasm Recurr

2009
[(11)C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy.
    World journal of urology, 2009, Volume: 27, Issue:5

    Topics: Aged; Choline; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography;

2009
Dual tracer 11C-choline and FDG-PET in the diagnosis of biochemical prostate cancer relapse after radical treatment.
    Molecular imaging and biology, 2010, Volume: 12, Issue:2

    Topics: Adult; Aged; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neopl

2010
Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2009, Volume: 50, Issue:9

    Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Humans; Male; Metabolic Clearance Rate; Midd

2009
18F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2009, Volume: 93, Issue:2

    Topics: Aged; Aged, 80 and over; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Neoplasm Recurr

2009
Detection of local, regional, and distant recurrence in patients with psa relapse after external-beam radiotherapy using (11)C-choline positron emission tomography.
    International journal of radiation oncology, biology, physics, 2010, May-01, Volume: 77, Issue:1

    Topics: Aged; Carbon Radioisotopes; Choline; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Po

2010
Distinction between glioma progression and post-radiation change by combined physiologic MR imaging.
    Neuroradiology, 2010, Volume: 52, Issue:4

    Topics: Adult; Aspartic Acid; Blood Volume; Brain; Brain Neoplasms; Cerebrovascular Circulation; Choline; Cr

2010
[Usefulness of PET scans in diagnosing recurrent prostate cancer. Prostate with PSA level < 5 ng/ml].
    Actas urologicas espanolas, 2009, Volume: 33, Issue:8

    Topics: Adult; Aged; Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local;

2009
MR spectroscopy for differentiation of recurrent glioma from radiation-induced changes.
    AJR. American journal of roentgenology, 2009, Volume: 193, Issue:6

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain Neoplasms; Child; Child, Preschool; Choline; Contrast

2009
3D MR-spectroscopic imaging assessment of metabolic activity in the prostate during the PSA "bounce" following 125iodine brachytherapy.
    International journal of radiation oncology, biology, physics, 2011, Feb-01, Volume: 79, Issue:2

    Topics: Brachytherapy; Choline; Citric Acid; Creatine; Humans; Iodine Radioisotopes; Magnetic Resonance Imag

2011
[11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging.
    The Journal of urology, 2010, Volume: 184, Issue:3

    Topics: Aged; Aged, 80 and over; Choline; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm St

2010
Promising role of [18F] fluorocholine PET/CT vs [18F] fluorodeoxyglucose PET/CT in primary brain tumors-early experience.
    Clinical neurology and neurosurgery, 2011, Volume: 113, Issue:2

    Topics: Brain Neoplasms; Choline; Fatal Outcome; Female; Fluorine Radioisotopes; Glioblastoma; Glioma; Human

2011
Treatment of children with recurrent high grade gliomas with a bevacizumab containing regimen.
    Journal of neuro-oncology, 2011, Volume: 103, Issue:3

    Topics: Adolescent; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anti

2011
Re: 11Ccholine positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging. G. Giovacchini, M. Picchio, A. Briganti, C. Cozzarin
    The Journal of urology, 2011, Volume: 185, Issue:3

    Topics: Choline; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; P

2011
Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer.
    International journal of radiation oncology, biology, physics, 2012, Feb-01, Volume: 82, Issue:2

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Carbon Radioisotopes; Choline; Disease-Free Survival;

2012
Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer.
    Urologic oncology, 2013, Volume: 31, Issue:4

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Feasibility Studies; Fluorine Radioisotopes; Follo

2013
[Usefulness of quantitative H-MR spectroscopy for the differentiation between radiation necrosis and recurrence of anaplastic oligodendroglioma].
    No shinkei geka. Neurological surgery, 2011, Volume: 39, Issue:5

    Topics: Adult; Aspartic Acid; Brain Diseases; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; F

2011
Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2011, Volume: 99, Issue:2

    Topics: Aged; Carbon Radioisotopes; Choline; Humans; Logistic Models; Lymphatic Metastasis; Male; Middle Age

2011
Role of ¹¹C-choline positron emission tomography/computed tomography in evaluating patients affected by prostate cancer with suspected relapse due to prostate-specific antigen elevation.
    Japanese journal of radiology, 2011, Volume: 29, Issue:6

    Topics: Aged; Choline; Contrast Media; Endpoint Determination; Humans; Male; Multimodal Imaging; Neoplasm Re

2011
MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Academic radiology, 2011, Volume: 18, Issue:9

    Topics: Adolescent; Adult; Aspartic Acid; Brain Neoplasms; Child; Child, Preschool; Choline; Creatine; Diagn

2011
Papillary glioneuronal tumor: unexplored entity.
    Journal of neurological surgery. Part A, Central European neurosurgery, 2012, Volume: 73, Issue:4

    Topics: Adult; Brain Neoplasms; Choline; Creatinine; Diffusion Magnetic Resonance Imaging; Female; Glioma; H

2012
Mediastinal lymph node uptake in patients with prostate carcinoma on F18-choline PET/CT.
    Nuclear medicine communications, 2011, Volume: 32, Issue:12

    Topics: Aged; Choline; Fluorine Radioisotopes; Humans; Lymph Nodes; Male; Mediastinum; Middle Aged; Multimod

2011
[11C]-choline PET/CT in imaging locally advanced prostate cancer.
    Nuclear medicine review. Central & Eastern Europe, 2011, Volume: 14, Issue:2

    Topics: Aged; Carbon Radioisotopes; Choline; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; P

2011
[11C]choline PET for the intraprostatic tumor characterization and localization in recurrent prostate cancer after EBRT.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2012, Volume: 56, Issue:2

    Topics: Aged; Carbon Radioisotopes; Choline; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local;

2012
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy.
    International journal of radiation oncology, biology, physics, 2012, Nov-01, Volume: 84, Issue:3

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Choline; Combined Moda

2012
Role of 11C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy.
    European journal of radiology, 2012, Volume: 81, Issue:8

    Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Bone and Bones; Carbon Radioisotopes; Choline; Humans; M

2012
[18F]choline positron emission tomography in prostate cancer patients with biochemical recurrence after radical prostatectomy: influence of antiandrogen therapy - a preliminary study.
    Nuclear medicine communications, 2012, Volume: 33, Issue:8

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Choline; Fluorine Radioisotopes; Follow-Up Studies; H

2012
Impact of total PSA, PSA doubling time and PSA velocity on detection rates of 11C-Choline positron emission tomography in recurrent prostate cancer.
    World journal of urology, 2013, Volume: 31, Issue:2

    Topics: Aged; Biomarkers, Tumor; Carbon Radioisotopes; Choline; Disease Progression; Humans; Kallikreins; Ma

2013
[11C]Choline-PET/CT for outcome prediction of salvage radiotherapy of local relapsing prostate carcinoma.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2012, Volume: 56, Issue:5

    Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Multimodal Imagin

2012
Operational characteristics of (11)c-choline positron emission tomography/computerized tomography for prostate cancer with biochemical recurrence after initial treatment.
    The Journal of urology, 2013, Volume: 189, Issue:4

    Topics: Adult; Aged; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm

2013
[11C]choline positron emission tomography/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigen.
    The Journal of urology, 2013, Volume: 189, Issue:1

    Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Early Detection of Cancer; Humans; Male; Mid

2013
Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis.
    Neurosurgery, 2002, Volume: 51, Issue:4

    Topics: Adult; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Glioma; Humans; Lactic Acid; Lip

2002
In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience.
    Radiology, 2002, Volume: 225, Issue:3

    Topics: Adult; Astrocytoma; Biopsy; Brain; Brain Neoplasms; Choline; Diagnosis, Differential; Female; Gliobl

2002
[The (11C) acetate positron emission tomography in prostatic carcinoma. New prospects in metabolic imaging].
    Der Urologe. Ausg. A, 2002, Volume: 41, Issue:6

    Topics: Acetates; Adenocarcinoma; Amino Acids; Biopsy; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18

2002
Monitoring individual response to brain-tumour chemotherapy: proton MR spectroscopy in a patient with recurrent glioma after stereotactic radiotherapy.
    Neuroradiology, 2004, Volume: 46, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Astrocytoma; Brain Neoplasms;

2004
[Usefulness of Cho/Cr ratio in proton MR spectroscopy for differentiating residual/recurrent glioma from non-neoplastic lesions].
    Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 2004, Volume: 64, Issue:3

    Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Choline; Creatine; Female; Glioma

2004
Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for Grade IV glioma.
    Journal of neurosurgery, 2004, Volume: 101, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain; Brain Mapping; Brain Neoplasms; Choline; Cohor

2004
123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.
    Journal of neuro-oncology, 2004, Volume: 70, Issue:1

    Topics: Adult; Aged; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Female; Glioblastoma; Huma

2004
Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.
    Journal of neuro-oncology, 2005, Volume: 71, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Aspartic Acid; Central Nervous Syst

2005
11C-choline positron emission tomography in prostate cancer: primary staging and recurrent site staging.
    Urologia internationalis, 2005, Volume: 74, Issue:3

    Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Drug Combinations; Feasibility Studies; Huma

2005
Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
    International journal of radiation oncology, biology, physics, 2005, May-01, Volume: 62, Issue:1

    Topics: Aspartic Acid; Brain Stem Neoplasms; Child; Child, Preschool; Choline; Creatine; Disease Progression

2005
Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
    AJR. American journal of roentgenology, 2005, Volume: 185, Issue:6

    Topics: Adolescent; Adult; Aspartic Acid; Brain Neoplasms; Child; Child, Preschool; Choline; Contrast Media;

2005
[Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2006, Volume: 178, Issue:6

    Topics: Adult; Aspartic Acid; Astrocytoma; Brain; Brain Neoplasms; Chemotherapy, Adjuvant; Choline; Combined

2006
Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    International journal of radiation oncology, biology, physics, 2007, May-01, Volume: 68, Issue:1

    Topics: Adult; Aged; Aspartic Acid; Brain; Brain Neoplasms; Choline; Diagnosis, Differential; Diffusion Magn

2007
Detection and management of isolated lymph node recurrence in patients with PSA relapse.
    European urology, 2007, Volume: 52, Issue:2

    Topics: Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Prosta

2007
Editorial comment on: Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
    European urology, 2007, Volume: 52, Issue:2

    Topics: Aged; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurr

2007
Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
    European urology, 2007, Volume: 52, Issue:2

    Topics: Aged; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurr

2007
Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
    European urology, 2007, Volume: 52, Issue:2

    Topics: Aged; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurr

2007
Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
    European urology, 2007, Volume: 52, Issue:2

    Topics: Aged; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurr

2007
Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
    European urology, 2007, Volume: 52, Issue:2

    Topics: Aged; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurr

2007
18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy.
    BJU international, 2007, Volume: 99, Issue:6

    Topics: Acetates; Aged; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Human

2007
[Pro and contra: 11C choline PET in diagnosis of prostate cancer].
    Aktuelle Urologie, 2007, Volume: 38, Issue:3

    Topics: Carbon Radioisotopes; Choline; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imagi

2007
Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer.
    BJU international, 2007, Volume: 100, Issue:4

    Topics: Aged; Choline; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm St

2007
Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer.
    BJU international, 2007, Volume: 100, Issue:4

    Topics: Aged; Choline; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm St

2007
Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer.
    BJU international, 2007, Volume: 100, Issue:4

    Topics: Aged; Choline; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm St

2007
Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer.
    BJU international, 2007, Volume: 100, Issue:4

    Topics: Aged; Choline; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm St

2007
[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy.
    European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:1

    Topics: Adenocarcinoma; Aged; Biopsy; Carbon Radioisotopes; Choline; Follow-Up Studies; Humans; Male; Middle

2008
Fluoromethylcholine PET in recurrent multifocal hepatoma.
    Australasian radiology, 2007, Volume: 51 Suppl

    Topics: Carcinoma, Hepatocellular; Choline; Female; Humans; Image Enhancement; Liver Neoplasms; Middle Aged;

2007
Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.
    BJU international, 2008, Volume: 102, Issue:4

    Topics: Analysis of Variance; Carbon Radioisotopes; Choline; Humans; Length of Stay; Lymph Node Excision; Ly

2008
Role of whole-body 18F-choline PET/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer.
    La Radiologia medica, 2008, Volume: 113, Issue:6

    Topics: Aged; Biopsy; Choline; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pos

2008
Hydrogen magnetic resonance spectroscopy follow-up after radiation therapy of human brain cancer. Unexpected inverse correlation between the changes in tumor choline level and post-gadolinium magnetic resonance imaging contrast.
    Investigative radiology, 1995, Volume: 30, Issue:12

    Topics: Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Energy Metabolism; Follow-Up Studies; Four

1995
Proton MR spectroscopy of squamous cell carcinoma of the upper aerodigestive tract: in vitro characteristics.
    AJNR. American journal of neuroradiology, 1996, Volume: 17, Issue:8

    Topics: Carcinoma, Squamous Cell; Choline; Confidence Intervals; Creatine; Esophageal Neoplasms; Esophagus;

1996
Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.
    Journal of neurosurgery, 1997, Volume: 87, Issue:4

    Topics: Adult; Aged; Aspartic Acid; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Cell Transformation, Neoplas

1997
Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy.
    Journal of neurosurgery, 1997, Volume: 87, Issue:4

    Topics: Aspartic Acid; Brachytherapy; Brain; Brain Neoplasms; Choline; Contrast Media; Creatine; Disease Pro

1997
Proton MR spectroscopy of delayed cerebral radiation in monkeys and humans after brachytherapy.
    AJNR. American journal of neuroradiology, 1997, Volume: 18, Issue:9

    Topics: Adult; Animals; Aspartic Acid; Brachytherapy; Brain; Brain Neoplasms; Choline; Cranial Irradiation;

1997
Proton (1H) MR spectroscopy for routine diagnostic evaluation of brain lesions.
    Acta radiologica (Stockholm, Sweden : 1987), 1997, Volume: 38, Issue:6

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain Diseases; Brain Neo

1997
Magnetic resonance spectroscopy guided brain tumor resection: differentiation between recurrent glioma and radiation change in two diagnostically difficult cases.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1998, Volume: 25, Issue:1

    Topics: Adult; Brain; Brain Neoplasms; Choline; Combined Modality Therapy; Diagnosis, Differential; Glioma;

1998
Pediatric low-grade gliomas: prognosis with proton magnetic resonance spectroscopic imaging.
    Neurosurgery, 1998, Volume: 43, Issue:4

    Topics: Adolescent; Aspartic Acid; Astrocytoma; Brain; Brain Neoplasms; Cell Division; Child; Child, Prescho

1998
Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.
    Journal of neurosurgery, 1999, Volume: 91, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antigens, Nuclear; Biomarkers, Tumor; Brain; Cell Division; Cell Tra

1999
Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy.
    Neurosurgery, 2000, Volume: 46, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Aspartic Acid; Astro

2000
A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas.
    Neurosurgery, 2000, Volume: 46, Issue:2

    Topics: Adult; Aged; Aspartic Acid; Astrocytoma; Choline; Creatine; Female; Glioblastoma; Humans; Lactic Aci

2000
Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas.
    AJNR. American journal of neuroradiology, 2000, Volume: 21, Issue:2

    Topics: Adult; Aspartic Acid; Blood Volume; Brain; Brain Neoplasms; Choline; Combined Modality Therapy; Fema

2000
Effect of voxel position on single-voxel MR spectroscopy findings.
    AJNR. American journal of neuroradiology, 2000, Volume: 21, Issue:2

    Topics: Aspartic Acid; Astrocytoma; Brain; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Glio

2000
Discrimination between neoplastic and nonneoplastic brain lesions by use of proton MR spectroscopy: the limits of accuracy with a logistic regression model.
    AJNR. American journal of neuroradiology, 2000, Volume: 21, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain; Brain Neoplasms; Choline; Diagnosi

2000
Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery.
    AJNR. American journal of neuroradiology, 2001, Volume: 22, Issue:4

    Topics: Adult; Aspartic Acid; Brain; Brain Neoplasms; Choline; Energy Metabolism; Female; Follow-Up Studies;

2001
An efficient chemical shift imaging scheme for magnetic resonance-guided neurosurgery.
    Journal of magnetic resonance imaging : JMRI, 2001, Volume: 14, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Astrocytoma; Biopsy; Brain; Brain Mapping; Brain Neop

2001
[1H-MR Spectroscopy of brain tumors in the course of radiation therapy: Use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2002, Volume: 174, Issue:1

    Topics: Adult; Aged; Brain; Brain Neoplasms; Choline; Combined Modality Therapy; Cranial Irradiation; Energy

2002
Neuroimaging in pediatric brain tumors: Gd-DTPA-enhanced, hemodynamic, and diffusion MR imaging compared with MR spectroscopic imaging.
    AJNR. American journal of neuroradiology, 2002, Volume: 23, Issue:2

    Topics: Adolescent; Blood Volume; Brain Neoplasms; Cerebrovascular Circulation; Child; Child, Preschool; Cho

2002
Hexadecylphosphocholine, a new ether lipid analogue. Studies on the antineoplastic activity in vitro and in vivo.
    Acta oncologica (Stockholm, Sweden), 1989, Volume: 28, Issue:2

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Choline; Drug Screening Assays, Antitumor; Female;

1989
Hexadecylphosphocholine (D 18506) in the topical treatment of skin metastases: a phase-I trial.
    Onkologie, 1988, Volume: 11, Issue:6

    Topics: Administration, Topical; Breast Neoplasms; Choline; Drug Evaluation; Female; Humans; Neoplasm Recurr

1988
[Chlorcolchicine in the localized treatment of skin tumors].
    Schweizerische medizinische Wochenschrift, 1974, Feb-23, Volume: 104, Issue:8

    Topics: Administration, Topical; Antineoplastic Agents; Carcinoma, Basal Cell; Chemistry, Pharmaceutical; Ch

1974